Richard Blyton Devereux

Q: What Schools Are Affiliated With Richard Blyton Devereux

Richard Blyton Devereux is affiliated with the following schools: University of Alabama at Birmingham, University of Oslo, Boston University, University of Oxford, Wake Forest University, Charles University, University of Oklahoma Health Sciences Center, University of Southern California, United States Military Academy, Cornell University, Kumoh National Institute of Technology, University of California, San Francisco, Ghent University, University of Bergen, Umeå University, Johns Hopkins University, Oregon Health & Science University

Richard Blyton Devereux's AcademicInfluence.com Rankings

Medical

#382

World Rank

#536

Historical Rank

Cardiology

World Rank

Historical Rank

medical Degrees

Richard Blyton Devereux

Philosophy

#1861

World Rank

#3293

Historical Rank

Logic

#339

World Rank

#672

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Richard Blyton Devereux's Degrees

PhD Cardiology Stanford University

Why Is Richard Blyton Devereux Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Richard Blyton Devereux's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio (2005) (10777)
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. (1989) (8468)
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. (1986) (6069)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (2002) (5504)
Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method (1977) (4594)
Recommendations for chamber quantification. (2006) (4020)
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. (1991) (2397)
The revised Ghent nosology for the Marfan syndrome (2010) (1659)
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (2002) (1631)
Revised diagnostic criteria for the Marfan syndrome. (1996) (1563)
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. (2003) (1439)
Central Pressure More Strongly Relates to Vascular Disease and Outcome Than Does Brachial Pressure: The Strong Heart Study (2007) (1178)
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. (1986) (1146)
Two-dimensional echocardiographic aortic root dimensions in normal children and adults. (1989) (1045)
Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. (2007) (959)
Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study (2004) (942)
American Society of Echocardiography recommendations for use of echocardiography in clinical trials. (2004) (920)
Impact of diabetes on cardiac structure and function: the strong heart study. (2000) (909)
Prognostic significance of left ventricular mass change during treatment of hypertension. (2004) (836)
Standardization of M-mode echocardiographic left ventricular anatomic measurements. (1984) (789)
Prognostic implications of left ventricular hypertrophy. (2001) (704)
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. (1983) (701)
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. (1999) (678)
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. (2005) (666)
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study (2005) (603)
Life expectancy in the Marfan syndrome. (1995) (582)
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. (2004) (574)
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. (1987) (555)
Detection of Left Ventricular Hypertrophy by M‐Mode Echocardiography: Anatomic Validation, Standardization, and Comparison to Other Methods (1987) (547)
Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. (1985) (546)
Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial (2004) (481)
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. (2002) (469)
Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. (1999) (467)
Left Ventricular Hypertrophy: Relationship of Anatomic, Echocardiographic and Electrocardiographic Findings (1981) (457)
Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance. (2015) (449)
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. (1986) (446)
Mitral Ratio of Peak Early to Late Diastolic Filling Velocity as a Predictor of Mortality in Middle-Aged and Elderly Adults: The Strong Heart Study (2002) (440)
Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. (2008) (439)
The heart in hypertension. (1992) (438)
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (2002) (416)
Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. (2000) (413)
The relationship between 'job strain,' workplace diastolic blood pressure, and left ventricular mass index. Results of a case-control study. (1990) (406)
Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. (1996) (398)
Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. (1992) (398)
Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. (1992) (395)
Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. (1995) (390)
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). (2006) (370)
The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. (2001) (368)
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. (1997) (356)
Mitral valve prolapse. (1976) (351)
Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects: Hypertension Genetic Epidemiology Network (HyperGEN) Study (2001) (342)
Remodeling and reparation of the cardiovascular system. (1992) (341)
Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. (1983) (339)
Preclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis (2006) (326)
Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. (1999) (317)
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. (1998) (313)
Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. (2003) (308)
Risk of a thrombotic event after the 6-week postpartum period. (2014) (308)
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. (1993) (306)
Arterial Stiffness in Chronic Inflammatory Diseases (2005) (305)
Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight. (1997) (303)
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. (1998) (302)
Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. (1990) (302)
What is the value of home blood pressure measurement in patients with mild hypertension? (1984) (298)
Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age. (2012) (293)
LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. (2000) (289)
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. (2006) (278)
Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study (2003) (274)
Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. (2000) (272)
Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. (2006) (264)
Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination. (1990) (263)
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. (1990) (263)
Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample: The Strong Heart Study (2006) (258)
Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. (1988) (254)
Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension. (1983) (253)
Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. (1998) (249)
Cadmium Exposure and Incident Cardiovascular Disease (2013) (247)
Correlates of Left Atrial Size in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (2002) (245)
Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study (2010) (241)
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. (2005) (240)
Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. (2007) (240)
Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study. (2000) (236)
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. (2008) (235)
Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. (1998) (234)
Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. (1992) (233)
Effects of Once-Daily Angiotensin-Converting Enzyme Inhibition and Calcium Channel Blockade-Based Antihypertensive Treatment Regimens on Left Ventricular Hypertrophy and Diastolic Filling in Hypertension: The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PR (2001) (231)
Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. (1997) (230)
Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome. (1993) (225)
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. (2005) (224)
Reliable estimation of peak left ventricular systolic pressure by M-mode echographic-determined end-diastolic relative wall thickness: identification of severe valvular aortic stenosis in adult patients. (1982) (223)
Cardiac and Systemic Hemodynamic Characteristics of Hypertension and Prehypertension in Adolescents and Young Adults: The Strong Heart Study (2006) (221)
Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. (2009) (221)
Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. (2012) (220)
Differences in Left Ventricular Structure Between Black and White Hypertensive Adults: The Hypertension Genetic Epidemiology Network Study (2004) (218)
A Longitudinal Study of Hypertension Risk Factors and Their Relation to Cardiovascular Disease: The Strong Heart Study (2006) (216)
Inheritance of mitral valve prolapse: effect of age and sex on gene expression. (1982) (212)
What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? (1985) (210)
Evaluation of Concentric Left Ventricular Geometry in Humans: Evidence for Age-Related Systematic Underestimation (2005) (201)
Clinical practice. Patent foramen ovale in young adults with unexplained stroke. (2005) (190)
Identification of a Chromosome 11q23.2-q24 Locus for Familial Aortic Aneurysm Disease, a Genetically Heterogeneous Disorder (2001) (189)
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals (2011) (189)
Diagnosis and classification of severity of mitral valve prolapse: methodologic, biologic, and prognostic considerations. (1987) (188)
Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. (2009) (183)
Arrhythmias and sudden death in mitral valve prolapse. (1987) (182)
Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. (1986) (181)
Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study (2002) (181)
Change in Diastolic Left Ventricular Filling After One Year of Antihypertensive Treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (2002) (178)
Echocardiographic imaging in clinical trials: American Society of Echocardiography Standards for echocardiography core laboratories: endorsed by the American College of Cardiology Foundation. (2009) (178)
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study (2002) (177)
Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. (1993) (176)
Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death: The LIFE Study (2007) (176)
Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1 (2011) (175)
High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. (2009) (175)
Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial (2007) (175)
Cardiac chamber volumes, function, and mass as determined by 64-multidetector row computed tomography: mean values among healthy adults free of hypertension and obesity. (2008) (174)
Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as the reference standard. Comparison of standard criteria, computer diagnosis and physician interpretation. (1984) (174)
Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. (2006) (172)
Natural history of mitral valve prolapse. (1995) (172)
Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). (2004) (171)
Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. (1984) (170)
Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). (1996) (170)
Mitral valve prolapse: causes, clinical manifestations, and management. (1989) (170)
Aortic root dilatation as a cause of isolated, severe aortic regurgitation. Prevalence, clinical and echocardiographic patterns, and relation to left ventricular hypertrophy and function. (1987) (170)
Mitral Annular Calcification, Aortic Valve Sclerosis, and Incident Stroke in Adults Free of Clinical Cardiovascular Disease: The Strong Heart Study (2005) (165)
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. (2007) (164)
H35: Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension study (1997) (161)
Mitral valve prolapse in the general population. 2. Clinical features: the Framingham Study. (1983) (160)
Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. (1994) (158)
Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). (2001) (157)
Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). (2001) (156)
Mitral regurgitation: relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients. (1986) (156)
Genetic Determinants of Lipid Traits in Diverse Populations from the Population Architecture using Genomics and Epidemiology (PAGE) Study (2011) (153)
Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. (2003) (151)
Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study. (2000) (150)
Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. (1999) (150)
Recommendations Concerning Use of Echocardiography in Hypertension and General Population Research (1987) (150)
QRS Duration and QT Interval Predict Mortality in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention for Endpoint Reduction in Hypertension Study (2004) (148)
Left Ventricular Hypertrophy in Hypertension Prevalence and Relationship to Pathophysiologic Variables (1987) (148)
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. (2002) (147)
Mitral valve prolapse in the general population. 3. Dysrhythmias: the Framingham Study. (1983) (147)
Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome. (1999) (146)
Association Between Exposure to Low to Moderate Arsenic Levels and Incident Cardiovascular Disease (2013) (146)
All-Cause Morality and Cardiovascular Disease Mortality in Three American Indian Populations, Aged 45–74 Years, 1984–1988 The Strong Heart Study (1998) (145)
Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart Study. (2001) (143)
Left Ventricular Morphology and Systolic Function in Sleep-Disordered Breathing: The Sleep Heart Health Study (2008) (143)
Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories. (2014) (140)
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy (2004) (139)
Risk Factors for Arterial Hypertension in Adults With Initial Optimal Blood Pressure: The Strong Heart Study (2006) (137)
Incidence and Risk Factors for Stroke in American Indians: The Strong Heart Study (2008) (136)
Increased cardiac performance in mild essential hypertension. Left ventricular mechanics. (1985) (134)
Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. (2000) (133)
Reproducibility of Echocardiographic Left Ventricular Measurements (1987) (132)
Prevalence of peripheral arterial disease and associated risk factors in American Indians: the Strong Heart Study. (1999) (131)
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis. (2020) (131)
Complications of mitral valve prolapse. Disproportionate occurrence in men and older patients. (1986) (128)
Left ventricular mass change during treatment and outcome in patients with essential hypertension. (2002) (128)
Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study (2010) (128)
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study. (2004) (128)
Baseline Characteristics in Relation to Electrocardiographic Left Ventricular Hypertrophy in Hypertensive Patients: The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study (2000) (128)
Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population With High Prevalence of Obesity and Diabetes (2007) (127)
Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study). (2001) (127)
Echocardiographic Left Ventricular Geometry in Hypertensive Patients with Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study (2001) (126)
Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients (2004) (126)
Echocardiographic Algorithm for Post-Myocardial Infarction LV Thrombus: A Gatekeeper for Thrombus Evaluation by Delayed Enhancement CMR. (2016) (125)
Assessment of the thoracic aorta by multidetector computed tomography: age- and sex-specific reference values in adults without evident cardiovascular disease. (2008) (125)
Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). (2008) (124)
Left Ventricular Hypertrophy and Function in High, Normal, and Low‐Renin Forms of Essential Hypertension (1982) (124)
Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. (2014) (124)
Relation between the presence of echocardiographic vegetations and the complication rate in infective endocarditis. (1986) (124)
Change in Diastolic Left Ventricular Filling After One Year of Antihypertensive Treatment (2002) (124)
Heritability of Carotid Artery Structure and Function: The Strong Heart Family Study (2002) (123)
Multidetector computed tomography coronary artery plaque predictors of stress-induced myocardial ischemia by SPECT. (2008) (122)
Gender Differences in Left Ventricular Structure and Function During Antihypertensive Treatment: The Losartan Intervention for Endpoint Reduction in Hypertension Study (2008) (121)
Left ventricular hypertrophy in black and white hypertensives. Standard electrocardiographic criteria overestimate racial differences in prevalence. (1992) (121)
Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study. (2004) (119)
Comparison of left ventricular mass and geometry in black and white patients with essential hypertension. (1993) (119)
Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. (2006) (118)
Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. (2008) (117)
Cardiovascular events during differing hypertension therapies in patients with diabetes. (2010) (116)
Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults. (1991) (115)
The relationship between 'job strain,' workplace diastolic blood pressure, and left ventricular mass index: a correction. (1992) (115)
Relationship between the level, pattern and variability of ambulatory blood pressure and target organ damage in hypertension. (1991) (115)
Ethnic Differences in Arterial Wave Reflections and Normative Equations for Augmentation Index (2011) (113)
Prevalence and correlates of aortic regurgitation in American Indians: the Strong Heart Study. (2000) (112)
Cardiovascular and Metabolic Predictors of Progression of Prehypertension Into Hypertension: The Strong Heart Study (2009) (112)
Echocardiographic left ventricular mass and electrolyte intake predict arterial hypertension. (1991) (112)
Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: the Strong Heart Study. (2001) (111)
Relation between clinical features of the mitral prolapse syndrome and echocardiographically documented mitral valve prolapse. (1986) (111)
Is the absence of a normal nocturnal fall in blood pressure (nondipping) associated with cardiovascular target organ damage? (1997) (111)
Repolarization abnormalities of left ventricular hypertrophy. Clinical, echocardiographic and hemodynamic correlates. (1982) (110)
Environmental influences on blood pressure and the role of job strain. (1996) (110)
Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. (2001) (110)
Principal Component Analysis of the T Wave and Prediction of Cardiovascular Mortality in American Indians: The Strong Heart Study (2002) (109)
Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity. (1996) (108)
Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study. (2005) (107)
Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications. (1994) (106)
Ambulatory monitoring of blood pressure as a predictor of cardiovascular risk. (1987) (106)
Gender differences and the electrocardiogram in left ventricular hypertrophy. (1995) (106)
Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. (1998) (104)
Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study (2005) (104)
Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies. (2005) (104)
Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. (2002) (103)
Changes in cardiovascular disease risk factors among American Indians. The Strong Heart Study. (2002) (103)
Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival. (1995) (101)
Pregnancy and the Risk of Aortic Dissection or Rupture: A Cohort-Crossover Analysis (2016) (101)
Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study (2005) (100)
Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the Strong Heart Study. (2001) (100)
C-Reactive Protein as a Predictor of Cardiovascular Risk in a Population With a High Prevalence of Diabetes: The Strong Heart Study (2005) (100)
Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. (2009) (99)
Prediction of Coronary Heart Disease in a Population With High Prevalence of Diabetes and Albuminuria: The Strong Heart Study (2006) (99)
Cost‐Effectiveness of Echocardiography and Electrocardiography for Detection of Left Ventricular Hypertrophy in Patients with Systemic Hypertension (1987) (99)
Hypertension in adult American Indians. The Strong Heart Study. (1996) (99)
Paroxysmal Supraventricular Tachycardia and the Risk of Ischemic Stroke (2013) (99)
Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients (2007) (98)
Relations of Doppler stroke volume and its components to left ventricular stroke volume in normotensive and hypertensive American Indians: the Strong Heart Study. (1997) (98)
52 Genetic Loci Influencing Myocardial Mass. (2016) (98)
Dietary intakes vary with age among Eskimo adults of Northwest Alaska in the GOCADAN study, 2000-2003. (2005) (98)
A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study. (2001) (97)
Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy. (1998) (97)
Incidence of diabetes in American Indians of three geographic areas: the Strong Heart Study. (2002) (97)
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. (2001) (96)
Costs and clinical outcomes after coronary multidetector CT angiography in patients without known coronary artery disease: comparison to myocardial perfusion SPECT. (2008) (95)
Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study (2002) (94)
Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: contrast to arrhythmias in mitral valve prolapse without mitral regurgitation. (1985) (94)
All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy. (2010) (94)
Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome. (1989) (92)
Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy). (2005) (91)
Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. (2003) (90)
Geometric Determinants of Electrocardiographic Left Ventricular Hypertrophy (1983) (89)
Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE Study (2006) (88)
Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension (2001) (88)
Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint. (2001) (87)
Left ventricular geometry, pathophysiology and prognosis. (1995) (87)
Four-Group Classification of Left Ventricular Hypertrophy Based on Ventricular Concentricity and Dilatation Identifies a Low-Risk Subset of Eccentric Hypertrophy in Hypertensive Patients (2014) (87)
Change in Systolic Left Ventricular Performance After 3 Years of Antihypertensive Treatment: The Losartan Intervention for Endpoint (LIFE) Study (2002) (86)
Rationale of echocardiographic assessment of left ventricular wall stress and midwall mechanics in hypertensive heart disease. (2002) (86)
Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis (2015) (86)
Heritability of left ventricular dimensions and mass in American Indians: The Strong Heart Study (2004) (85)
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. (2002) (84)
Relation of age to left ventricular function in clinically normal adults. (1998) (84)
Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study (2003) (84)
Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study. (2008) (84)
All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. (1998) (83)
Mitral valve prolapse and infective endocarditis. (1987) (83)
Ambulatory Blood Pressure and M;etabolic Abnormalities in Hypertensive Subjects With Inappropriately High Left Ventricular Mass (1999) (82)
What is normal blood pressure? Comparison of ambulatory pressure level and variability in patients with normal or abnormal left ventricular geometry. (1993) (82)
Impact of Diabetes Mellitus on Regression of Electrocardiographic Left Ventricular Hypertrophy and the Prediction of Outcome During Antihypertensive Therapy: The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study (2006) (82)
Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. (1994) (82)
Left ventricular papillary muscles and trabeculae are significant determinants of cardiac MRI volumetric measurements: effects on clinical standards in patients with advanced systolic dysfunction. (2008) (81)
Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study (2011) (81)
Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. (2002) (81)
Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN study. Hypertension Genetic Epidemiology Network. (2001) (80)
Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19 (2020) (79)
Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). (2004) (79)
Effects of papillary muscles and trabeculae on left ventricular quantification: increased impact of methodological variability in patients with left ventricular hypertrophy (2008) (79)
Prevalence and Prognostic Significance of Wall-Motion Abnormalities in Adults Without Clinically Recognized Cardiovascular Disease: The Strong Heart Study (2007) (78)
Automated Segmentation of Routine Clinical Cardiac Magnetic Resonance Imaging for Assessment of Left Ventricular Diastolic Dysfunction (2009) (78)
Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). (2002) (75)
Left atrial systolic force and cardiovascular outcome. The Strong Heart Study. (2005) (75)
Effects of Losartan or Atenolol in Hypertensive Patients without Clinically Evident Vascular Disease: A Substudy of the LIFE Randomized Trial (2003) (75)
Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension. (1987) (74)
Variability of the ventricular response in atrial fibrillation and prognosis in chronic nonischemic mitral regurgitation. (1994) (74)
Possible role of increased blood viscosity in the hemodynamics of systemic hypertension. (2000) (74)
Echocardiographic detection of pressure-overload left ventricular hypertrophy: effect of criteria and patient population. (1987) (74)
Association Between Major Perioperative Hemorrhage and Stroke or Q-Wave Myocardial Infarction (2012) (74)
Association of Blood Pressure With Blood Viscosity in American Indians: The Strong Heart Study (2005) (73)
Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study. (1996) (73)
Systemic Lupus Erythematosus Predicts Increased Left Ventricular Mass (2007) (73)
Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review. (2014) (73)
Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study. (2001) (73)
Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension. (1988) (72)
Combined Echocardiographic Left Ventricular Hypertrophy and Electrocardiographic ST Depression Improve Prediction of Mortality in American Indians: The Strong Heart Study (2004) (72)
N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study. (2004) (72)
Association of central and peripheral blood pressures with intermediate cardiovascular phenotypes. (2014) (72)
Clinical Implications of Electrocardiographic Left Ventricular Strain and Hypertrophy in Asymptomatic Patients With Aortic Stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis Study (2012) (71)
Cardiac structure and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis. (1986) (71)
Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension. (2000) (71)
Lack of Reduction of Left Ventricular Mass in Treated Hypertension: The Strong Heart Study (2013) (71)
Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension. (1990) (71)
Contrast in cardiac anatomy and function between black and white patients with hypertension. (1984) (70)
Left ventricular geometry and function preceding neurally mediated syncope. (2000) (69)
Gender difference in diastolic function in hypertension (the HyperGEN study). (2002) (68)
Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC Registry. (2016) (68)
Risk of a Thrombotic Event After the 6-Week Postpartum Period (2014) (68)
Contrasting patterns of autonomic dysfunction in patients with mitral valve prolapse and panic attacks. (1987) (67)
Fatty acid consumption and metabolic syndrome components: the GOCADAN study. (2007) (66)
Relationship of Sudden Cardiac Death to New-Onset Atrial Fibrillation in Hypertensive Patients With Left Ventricular Hypertrophy (2013) (66)
Incidence of Atrial Fibrillation in Relation to Changing Heart Rate Over Time in Hypertensive Patients: The LIFE Study (2006) (65)
The Need for Standardized Methods for Measuring the Aorta: Multimodality Core Lab Experience From the GenTAC Registry. (2016) (63)
In vivo mitral valve morphology and motion in mitral valve prolapse. (1994) (63)
Prognostic Value of Changes in the Electrocardiographic Strain Pattern During Antihypertensive Treatment: The Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE) (2009) (63)
In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study (2007) (63)
Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression, and need for mitral valve surgery. (2000) (62)
Day-to-day variability of voltage measurements used in electrocardiographic criteria for left ventricular hypertrophy. (1990) (62)
Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study). (1999) (62)
Influence of obesity on left ventricular midwall mechanics in arterial hypertension. (1996) (62)
Left Ventricular Systolic Dysfunction in a Biracial Sample of Hypertensive Adults: The HyperGEN Study (2001) (62)
Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation. (2013) (62)
Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study. (2004) (61)
Effect of Lower On-Treatment Systolic Blood Pressure on the Risk of Atrial Fibrillation in Hypertensive Patients (2015) (61)
Relation of sudden death in pure mitral regurgitation, with and without mitral valve prolapse, to repetitive ventricular arrhythmias and right and left ventricular ejection fractions. (1987) (61)
Is the electrocardiogram still useful for detection of left ventricular hypertrophy? (1990) (61)
Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: The LIFE Study (2001) (61)
Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. (2002) (61)
Telomere length and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study (2011) (61)
Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study. (2005) (61)
A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methods (2005) (59)
Association of Pulse Pressure With New-Onset Atrial Fibrillation in Patients With Hypertension and Left Ventricular Hypertrophy: The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study (2012) (59)
Left ventricular diastolic dysfunction: early diastolic relaxation and late diastolic compliance. (1989) (59)
Impact of image analysis methodology on diagnostic and surgical classification of patients with thoracic aortic aneurysms. (2011) (59)
Short leukocyte telomere length predicts incidence and progression of carotid atherosclerosis in American Indians: The Strong Heart Family Study (2014) (58)
Arrhythmias in mitral valve prolapse. Effect of selection bias. (1984) (58)
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. (2004) (58)
Relationship between ambulatory and exercise blood pressure and cardiac structure. (1988) (57)
Aortic disease in Marfan's syndrome. (1999) (57)
Transthoracic three-dimensional echocardiographic reconstruction of left and right ventricles: in vitro validation and comparison with magnetic resonance imaging. (1997) (57)
Recent developments in the diagnosis and management of mitral valve prolapse (1995) (57)
Criteria for an informative trial of left ventricular hypertrophy regression. (1994) (56)
Change in cardiovascular risk profile by echocardiography in low- or medium-risk hypertension (2002) (56)
Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. (2001) (56)
Cardiovascular remodeling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study. (2002) (56)
Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart Study. (2003) (56)
Vascular Biomarkers in the Prediction of Clinical Cardiovascular Disease: The Strong Heart Study (2012) (56)
Cardiac and arterial hypertrophy and atherosclerosis in hypertension. (1994) (55)
Bivariate genetic association of KIAA1797 with heart rate in American Indians: the Strong Heart Family Study. (2010) (55)
Racial Differences in Incident Heart Failure During Antihypertensive Therapy (2011) (55)
Is High Pulse Pressure a Marker of Preclinical Cardiovascular Disease? (2005) (54)
Individual saturated fatty acids are associated with different components of insulin resistance and glucose metabolism: the GOCADAN study (2010) (54)
Improved Left Ventricular Mass Quantification With Partial Voxel Interpolation: In Vivo and Necropsy Validation of a Novel Cardiac MRI Segmentation Algorithm (2012) (54)
Function of the hypertrophied left ventricle at rest and during exercise. Hypertension and aortic stenosis. (1983) (54)
Effects of Losartan in Women With Hypertension and Left Ventricular Hypertrophy: Results From the Losartan Intervention For Endpoint Reduction in Hypertension Study (2008) (54)
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study (2004) (53)
QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study. (2009) (52)
Genetic Variation in NCAM1 Contributes to Left Ventricular Wall Thickness in Hypertensive Families (2011) (52)
Preoperative Predictors of Late Postoperative Outcome among Patients with Nonischemic Mitral Regurgitation with 'High Risk' Descriptors and Comparison with Unoperated Patients (2000) (51)
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study (2007) (51)
Relationship between ambulatory or exercise blood pressure and left ventricular structure: prognostic implications. (1990) (51)
Left ventricular mass as a predictor of development of hypertension. (1991) (51)
Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. (2003) (50)
Major clinical trials of hypertension: what should be done next? (2005) (50)
Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy (2015) (50)
Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study). (2001) (50)
Quantitative assessment of electrocardiographic strain predicts increased left ventricular mass: the Strong Heart Study. (2002) (50)
Geometric and functional correlates of electrocardiographic repolarization and voltage abnormalities in aortic regurgitation. (1987) (50)
Panic disorder in patients with mitral valve prolapse. (1982) (50)
Does increased blood pressure cause left ventricular hypertrophy or vice versa? (1990) (50)
Machine learning derived segmentation of phase velocity encoded cardiovascular magnetic resonance for fully automated aortic flow quantification (2019) (49)
Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study (2015) (49)
Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. (2007) (49)
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. (2000) (49)
The question of heterogeneity in Marfan syndrome (1995) (48)
Impact of diastolic dysfunction severity on global left ventricular volumetric filling - assessment by automated segmentation of routine cine cardiovascular magnetic resonance (2010) (48)
Hypertensive heart disease: relationship of silent ischemia to coronary artery disease and left ventricular hypertrophy. (1990) (48)
The role and clinical implications of diastolic dysfunction in aortic stenosis (2017) (47)
Relation of hemodynamic volume load to arterial and cardiac size. (1997) (47)
Medical Therapies for Heart Failure With Preserved Ejection Fraction. (2019) (47)
Genome-wide association study identifies single-nucleotide polymorphism in KCNB1 associated with left ventricular mass in humans: The HyperGEN Study (2009) (47)
Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study. (2009) (47)
Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy? (1997) (46)
Ventricular Hypertrophy and Hypertension (2006) (46)
Therapeutic options in minimizing left ventricular hypertrophy. (2000) (46)
Recurrent systemic embolization caused by aortic thrombi. (1994) (46)
Consumption of omega-3 fatty acids is not associated with a reduction in carotid atherosclerosis: the Genetics of Coronary Artery Disease in Alaska Natives study. (2008) (46)
Usefulness of subnormal midwall fractional shortening in predicting left ventricular exercise dysfunction in asymptomatic patients with systemic hypertension. (1997) (46)
Associations between angiotensinogen gene variants and left ventricular mass and function in the HyperGEN study. (2002) (45)
Electrocardiographic diagnosis of left ventricular hypertrophy by the time-voltage integral of the QRS complex. (1994) (45)
Effect of agalsidase alfa replacement therapy on Fabry disease-related hypertrophic cardiomyopathy: a 12- to 36-month, retrospective, blinded echocardiographic pooled analysis. (2009) (45)
Associations of Age and Sex With Marfan Phenotype: The National Heart, Lung, and Blood Institute GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) Registry (2017) (45)
Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration (2015) (45)
Cadmium Exposure and Incident Peripheral Arterial Disease (2013) (45)
Gender differences in left ventricular systolic function in American Indians (from the Strong Heart Study). (2006) (45)
966-41 Impact of Hypertension on Aortic Root Size and Prevalence of Aortic Regurgitation (1995) (44)
Efficacy and Duration of Benazepril Plus Amlodipine or Hydrochlorthiazide on 24-Hour Ambulatory Systolic Blood Pressure Control (2011) (44)
The role of behavioral factors in white coat and sustained hypertension. (1990) (44)
Left ventricular systolic dysfunction in a biracial sample of hypertensive adults: The Hypertension Genetic Epidemiology Network (HyperGEN) Study. (2001) (44)
Left ventricular mass as a measure of preclinical hypertensive disease. (1992) (44)
Association of pulse pressure with cardiovascular outcome is independent of left ventricular hypertrophy and systolic dysfunction: the Strong Heart Study. (2006) (44)
The right sided great vessels by cardiac multidetector computed tomography: normative reference values among healthy adults free of cardiopulmonary disease, hypertension, and obesity. (2009) (44)
Ventricular hypertrophy and hypertension: prognostic elements and implications for management. (2006) (43)
In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study (2010) (43)
Cardiac Geometry and Function in Diabetic or Prediabetic Adolescents and Young Adults (2011) (43)
Influence of sodium intake on in vivo left ventricular anatomy in experimental renovascular hypertension. (1993) (42)
Long-term implications of emergency versus elective proximal aortic surgery in patients with Marfan syndrome in the Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions Consortium Registry. (2012) (42)
Time-voltage area of the QRS for the identification of left ventricular hypertrophy. (1996) (42)
Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension (2017) (42)
Cardiovascular disease prevalence and its relation to risk factors in Alaska Eskimos. (2010) (41)
Reversal of left ventricular dilatation, hypertrophy, and dysfunction by valve replacement in aortic regurgitation. (1989) (41)
Genetic evidence that mutations in the COL1A1, COL1A2, COL3A1, or COL5A2 collagen genes are not responsible for mitral valve prolapse. (1989) (41)
Cardiac rate and rhythm in panic patients. (1987) (41)
Natural history of left ventricular performance at rest and during exercise after aortic valve replacement for aortic regurgitation. (1991) (41)
Low prevalence of mitral valve prolapse in patients with panic disorder. (1984) (40)
Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients. (2010) (40)
Echocardiographic Wall Motion Abnormalities in Hypertensive Patients With Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study (2003) (40)
Marked Regional Left Ventricular Heterogeneity in Hypertensive Left Ventricular Hypertrophy Patients: A Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Cardiovascular Magnetic Resonance and Echocardiographic Substudy (2008) (40)
International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. (2021) (40)
N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study (2004) (40)
Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study. (2005) (39)
Aortic valve sclerosis is associated with preclinical cardiovascular disease in hypertensive adults: the Hypertension Genetic Epidemiology Network study (2005) (39)
N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy (2006) (39)
The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC): results from phase I and scientific opportunities in phase II. (2011) (39)
Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy (2005) (39)
Impact of coronary computed tomographic angiography findings on the medical treatment and control of coronary artery disease and its risk factors. (2009) (39)
Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study. (2003) (39)
ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus. (1996) (39)
Body Build and Risk of Cardiovascular Events in Hypertension and Left Ventricular Hypertrophy: The LIFE (Losartan Intervention For Endpoint reduction in hypertension) Study (2005) (38)
Comparison of mitral valve dimensions and motion in mitral valve prolapse with severe mitral regurgitation to uncomplicated mitral valve prolapse and to mitral regurgitation without mitral valve prolapse. (1988) (38)
Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy (2008) (38)
Preoperative left and right ventricular performance in combined aortic and mitral regurgitation and comparison with isolated aortic or mitral regurgitation. (1990) (38)
Genetics of mitral valve prolapse. (1983) (38)
The Effects of Losartan Compared to Atenolol on Stroke in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy. The LIFE Study (2005) (37)
Relation of hemoglobin A1 and blood glucose to cardiac function in diabetes mellitus. (1985) (37)
Novel genetic variants contributing to left ventricular hypertrophy: the HyperGEN study (2009) (37)
Costs and in-hospital outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in commercial cases using a propensity score matched model. (2015) (37)
Heart rate is associated with red blood cell fatty acid concentration: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. (2010) (36)
Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essential hypertension. (2002) (36)
Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy (2005) (36)
Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction. (1989) (36)
Diagnosis and prognosis of mitral-valve prolapse. (1989) (36)
Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study. (2012) (36)
Genetic Influences on Aortic Root Size in American Indians: The Strong Heart Study (2002) (35)
Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study. (2010) (35)
Staged approach to combined repair of pectus excavatum and lesions of the heart. (1994) (35)
Mitral valve dimensions and motion in Marfan patients with and without mitral valve prolapse. Comparison to primary mitral valve prolapse and normal subjects. (1989) (35)
Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events. (1992) (34)
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study (2009) (34)
Ethnicity and socioeconomic status influence use of primary angioplasty in patients presenting with acute myocardial infarction. (2007) (34)
Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy (2005) (34)
Reduction of development of left ventricular hypertrophy in salt-loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition. (1996) (34)
Predictive value and limitations of the ST/HR slope. (1985) (33)
Magnetic Resonance Imaging Left Ventricular Mass Reduction With Fixed-Dose Angiotensin-Converting Enzyme Inhibitor–Based Regimens in Patients With High-Risk Hypertension (2009) (33)
Parity, postmenopausal estrogen use, and cardiovascular disease risk factors in American Indian women: the Strong Heart Study. (1997) (33)
Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis. (2014) (33)
Sensitivity of Echocardiography for Detection of Left Ventricular Hypertrophy (1983) (33)
Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. (2013) (32)
Blood pressure stress reactivity and left ventricular mass in a random community sample of African-American and caucasian men and women. (2006) (32)
A blood pressure independent association between glomerular albumin leakage and electrocardiographic left ventricular hypertrophy. The LIFE Study (2002) (32)
The Arg16Gly polymorphism of the β2-adrenergic receptor and left ventricular systolic function☆ (2003) (32)
Introduction: Left ventricular hypertrophy—Good or evil?☆ (1983) (32)
Computerized ST Depression Analysis Improves Prediction of All‐Cause and Cardiovascular Mortality: The Strong Heart Study (2001) (32)
Renal outcomes in hypertensive Black patients at high cardiovascular risk. (2012) (31)
Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study (2017) (31)
Ability of left ventricular stress-shortening relations, end-systolic stress/volume ratio and indirect indexes to detect severe contractile failure in ischemic or idiopathic dilated cardiomyopathy. (1989) (31)
Effect of electroconvulsive therapy on the electrocardiogram and echocardiogram. (1992) (31)
A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study. (2008) (31)
Myocardial mechano-energetic efficiency and insulin resistance in non-diabetic members of the Strong Heart Study cohort (2019) (30)
Fatty acids linked to cardiovascular mortality are associated with risk factors (2015) (30)
A whole genome scan for pulse pressure/stroke volume ratio in African Americans: the HyperGEN study. (2007) (30)
Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease. (1993) (30)
Importance of left ventricular mass as a predictor of cardiovascular morbidity in hypertension. (1989) (30)
Identification of a novel 5-base pair deletion in calcineurin B (PPP3R1) promoter region and its association with left ventricular hypertrophy. (2005) (30)
Right Ventricular Dysfunction Impairs Effort Tolerance Independent of Left Ventricular Function Among Patients Undergoing Exercise Stress Myocardial Perfusion Imaging (2016) (30)
Genome-Wide Linkage Mapping for Valve Calcification Susceptibility Loci in Hypertensive Sibships: The Hypertension Genetic Epidemiology Network Study (2007) (30)
Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy). (2004) (30)
Genetic Variations Associated With Echocardiographic Left Ventricular Traits in Hypertensive Blacks (2007) (29)
Major electrocardiographic abnormalities among American Indians aged 45 to 74 years (the Strong Heart Study). (1996) (29)
Echocardiographic Three-Dimensional Visualization of the Heart (1990) (29)
Chronic arsenic exposure and risk of carotid artery disease: The Strong Heart Study (2017) (29)
Association of carotid atherosclerosis with electrocardiographic myocardial ischemia and left ventricular hypertrophy. (1996) (29)
Left Atrial Strain Impairment Precedes Geometric Remodeling as a Marker of Post-Myocardial Infarction Diastolic Dysfunction. (2020) (29)
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study. (2005) (29)
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study (2004) (29)
Relative fat-free mass deficiency and left ventricular adaptation to obesity: the Strong Heart Study. (2013) (29)
Mitral valve dimensions and motion and familial transmission of mitral valve prolapse with and without mitral leaflet billowing. (1988) (29)
Cardiovascular Morbidity and Mortality in Hypertensive Patients With Lower Versus Higher Risk: A LIFE Substudy (2005) (29)
Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the Strong Heart Study (2008) (28)
Fasting Plasma Glucose and Hemoglobin A1c in Identifying and Predicting Diabetes (2011) (28)
Impact of diastolic doppler indices on exercise capacity in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy) (2002) (28)
Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudy. (2005) (28)
Pre-clinical cardiovascular disease and surrogate end-points in hypertension: does race influence target organ damage independent of blood pressure? (1998) (28)
Left atrial systolic force and cardiac markers of preclinical disease in hypertensive patients: the Hypertension Genetic Epidemiology Network (HyperGEN) Study. (2005) (28)
Prognostic Implications of Mitral Annular Plane Systolic Excursion in Patients with Hypertension and a Clinical Indication for Cardiac Magnetic Resonance Imaging: A Multicenter Study. (2019) (28)
Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study. (2012) (28)
Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study (2007) (27)
The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy (2008) (27)
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study (2009) (27)
Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study (2008) (27)
Aortic Dilatation Associated With Bicuspid Aortic Valve: Relation to Sex, Hemodynamics, and Valve Morphology (the National Heart Lung and Blood Institute-Sponsored National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions). (2017) (27)
Left ventricular hypertrophy as a surrogate end-point in hypertension. (1999) (26)
Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study☆ (2002) (26)
Left ventricular hypertrophy after hypertensive pregnancy disorders (2015) (26)
P Wave Area for Quantitative Electrocardiographic Assessment of Left Atrial Remodeling (2014) (26)
Initial left-ventricular mass predicts probability of uncontrolled blood pressure in arterial hypertension (2011) (26)
Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study (2007) (26)
Cardiac involvement in essential hypertension. Prevalence, pathophysiology, and prognostic implications. (1987) (26)
Electrocardiographic left atrial abnormalities and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy (2016) (26)
Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. (2004) (26)
Genetic variation in APOJ, LPL, and TNFRSF10B affects plasma fatty acid distribution in Alaskan Eskimos. (2010) (26)
Myocardial function and geometry in hypertensive subjects with low levels of afterload. (2002) (26)
Prevalence of mitral valve prolapse in panic disorder: effect of echocardiographic criteria. (1986) (26)
Peripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart Study. (2016) (26)
Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy. (2012) (26)
Comparison of estimated glomerular filtration rates and albuminuria in predicting risk of coronary heart disease in a population with high prevalence of diabetes mellitus and renal disease. (2011) (26)
Prolonged survival (62 years) with single ventricle. (1983) (26)
Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study) (2014) (26)
Effect of changing heart rate during treatment of hypertension on incidence of heart failure. (2012) (26)
Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study. (2012) (26)
Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study. (2013) (25)
Markers of Inflammation, Metabolic Risk Factors, and Incident Heart Failure in American Indians: The Strong Heart Study (2012) (25)
Hypertrophic and functional response to experimental chronic aortic regurgitation. (1988) (25)
Adverse association between diabetic retinopathy and cardiac structure and function. (2009) (25)
Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation (2010) (25)
Cardiovascular Characteristics in Subjects With Increasing Levels of Abnormal Glucose Regulation (2013) (25)
The impact of serum uric acid on cardiovascular outcomes in the LIFE study. (2004) (25)
Associations of aortic and mitral regurgitation with body composition and myocardial energy expenditure in adults with hypertension: the Hypertension Genetic Epidemiology Network study. (2003) (25)
Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart Study. (2008) (25)
Usefulness of subclinical left ventricular midwall dysfunction to predict cardiovascular mortality in patients with type 2 diabetes mellitus. (2014) (25)
Relation of insulin to left ventricular geometry and function in African American and white hypertensive adults: the HyperGEN study. (2002) (25)
Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study. (2009) (24)
Cranial Magnetic Resonance Imaging in Elderly American Indians: Design, Methods, and Implementation of the Cerebrovascular Disease and Its Consequences in American Indians Study (2016) (24)
Comparison of cardiac computed tomographic angiography to transesophageal echocardiography for evaluation of patients with native valvular heart disease. (2009) (24)
Incremental Value of Biochemical and Echocardiographic Measures in Prediction of Ischemic Stroke: The Strong Heart Study (2012) (24)
Echocardiographic left ventricular mass measurement in small animals: anatomic validation in normal and aortic regurgitant rabbits (1990) (24)
An appraisal of echocardiography as an epidemiological tool. The Strong Heart Study. (2003) (24)
A family study of anterior mitral leaflet thickness and mitral valve prolapse. (1998) (24)
Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study (2013) (24)
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies (2007) (24)
Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study (2009) (24)
Variants in CPT1A, FADS1, and FADS2 are Associated with Higher Levels of Estimated Plasma and Erythrocyte Delta-5 Desaturases in Alaskan Eskimos (2012) (23)
Recruitment and community interactions in the gocadan study (2006) (23)
The ratio of mitral deceleration time to E-wave velocity and mitral deceleration slope outperform deceleration time alone in predicting cardiovascular outcomes: the Strong Heart Study. (2007) (23)
Cadmium exposure and incident peripheral arterial disease. (2013) (23)
Relation of albuminuria to left ventricular mass (from the HyperGEN Study). (2008) (23)
Blood pressure responses to acute stress and left ventricular mass (The Hypertension Genetic Epidemiology Network Study). (2002) (23)
A Gene-Family Analysis of 61 Genetic Variants in the Nicotinic Acetylcholine Receptor Genes for Insulin Resistance and Type 2 Diabetes in American Indians (2012) (23)
Risk of dysphagia after transesophageal echocardiography. (1991) (23)
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study). (2015) (23)
Appetite suppressants and valvular heart disease. (1998) (23)
International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. (2021) (23)
Extent and severity of coronary artery disease by coronary CT angiography is associated with elevated left ventricular diastolic pressures and worsening diastolic function. (2013) (23)
Electrocardiographic recognition of left atrial enlargement. (1983) (22)
Echocardiographic Linear Dimensions for Assessment of Right Ventricular Chamber Volume as Demonstrated by Cardiac Magnetic Resonance. (2016) (22)
Early infarct expansion: structural or functional? (1985) (22)
Effect of dietary sodium and potassium intake on left ventricular diastolic function and mass in adults≤40 years (from the Strong Heart Study). (2015) (22)
Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions. (2009) (22)
Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study (2006) (22)
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy (2007) (22)
Fatty acids linked to cardiovascular mortality are associated with risk factors. (2015) (21)
Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study. (2013) (21)
Relation between mitral annular calcium and complex aortic atheroma in patients with cerebral ischemia referred for transesophageal echocardiography. (2007) (21)
Machine Learning Prediction of Stroke Mechanism in Embolic Strokes of Undetermined Source (2020) (21)
Relationship of Electrocardiographic Left Ventricular Hypertrophy to the Presence of Diastolic Dysfunction (2014) (21)
Left ventricular mass in children and adolescents. (1988) (21)
Hemodynamic Correlates of Abnormal Aortic Root Dimension in an Adult Population: The Strong Heart Study (2015) (21)
Heritability and genetic linkage of left ventricular mass, systolic and diastolic function in hypertensive African Americans (From the GENOA Study). (2010) (21)
Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study (2009) (21)
Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study. (2008) (20)
Safety and Feasibility of Achieving Lower Systolic Blood Pressure Goals in Persons With Type 2 Diabetes: The SANDS Trial (2009) (20)
PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY. (2009) (20)
Lipoprotein (a) level, apolipoprotein (a) size, and risk of unexplained ischemic stroke in young and middle-aged adults. (2016) (20)
Editor's Choice - Aortic Re-operation After Replacement of the Proximal Aorta: A Systematic Review and Meta-Analysis. (2018) (20)
Losartan benefits over atenolol in non‐smoking hypertensive patients with left ventricular hypertrophy: The LIFE study (2004) (20)
Immediate of Impact Prosthetic Graft Replacement of the Ascending Aorta on Circumferential Strain in the Descending Aorta. (2019) (20)
Aortic root geometry in aortic stenosis patients (a SEAS substudy). (2011) (20)
Left Ventricular Wall Stress–Mass–Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE Study (2015) (20)
Depressed Myocardial Energetic Efficiency Increases Risk of Incident Heart Failure: The Strong Heart Study (2019) (20)
Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE Study. (2001) (20)
Association of Arsenic Exposure With Cardiac Geometry and Left Ventricular Function in Young Adults. (2019) (20)
Midwall LV mechanics in rats with or without renovascular hypertension: effect of different Na+ intakes. (1996) (20)
Health‐Related Quality of Life in Children and Young Adults with Marfan Syndrome (2019) (20)
Hemoglobin A1c, Fasting Glucose, and Cardiovascular Risk in a Population With High Prevalence of Diabetes (2011) (20)
Clinical and health care cost consequences of infective endocarditis in mitral valve prolapse. (1994) (19)
Common set of genes regulates low‐density lipoprotein size and obesity‐related factors in Alaskan Eskimos: Results from the GOCADAN Study (2006) (19)
Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy). (2009) (19)
Mitral Valve Prolapse in Blacks (1982) (19)
Stroke in Patients With Aortic Stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis Study (2014) (19)
Left ventricular diastolic and systolic performance during chronic experimental aortic regurgitation. (1992) (19)
24-h Ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy: left ventricular geometry and urinary albumin excretion—a LIFE substudy (2004) (19)
Genome-wide joint SNP and CNV analysis of aortic root diameter in African Americans: the HyperGEN study (2011) (19)
Effect of myocardial perfusion pattern on frequency and severity of mitral regurgitation in patients with known or suspected coronary artery disease. (2014) (19)
Left ventricular performance in the hypertensive patient. Exercise-mediated noninvasive separation of loading influences from intrinsic muscle dysfunction. (1983) (19)
Corrigendum to “Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: The Strong Heart Study” [Nutr Metab Cardiovasc Dis 19 (2009) 98–104] (2009) (19)
Sibling Resemblance for Left Ventricular Structure, Contractility, and Diastolic Filling (2002) (18)
Effect of total lymphoid irradiation on functional status in chronic multiple sclerosis: Importance of lymphopenia early after treatment—The pros (1988) (18)
GENOME-WIDE LINKAGE ANALYSIS OF CAROTID ARTERY LUMEN DIAMETER IN AMERICAN INDIANS: THE STRONG HEART FAMILY STUDY (2012) (18)
Mitral valve prolapse. (1979) (18)
Left ventricular hypertrophy and hypertension. (1993) (18)
Gastrointestinal hemorrhage--an unusual manifestation of neurofibromatosis. (1975) (18)
Toward a more complete understanding of left ventricular afterload. (1991) (18)
Echocardiographic insights into the pathophysiology and prognostic significance of hypertensive cardiac hypertrophy. (1989) (18)
Antihypertensive Treatment With β‐Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events (2017) (18)
Relationship between abnormal P-wave terminal force in lead V1 and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study (2017) (17)
TGF&bgr;RIIb Mutations Trigger Aortic Aneurysm Pathogenesis by Altering Transforming Growth Factor &bgr;2 Signal Transduction (2012) (17)
Mechanism, effects, and reversal of left ventricular hypertrophy in hypertension. (1993) (17)
Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint study (2014) (17)
Relationship of atrial natriuretic factor to left ventricular volume and mass. (1989) (17)
Superiority of ambulatory to physician blood pressure is not an artifact of differential measurement reliability (2006) (17)
Role of Doppler and imaging echocardiography in selection of patients for cardiac valvular surgery. (1987) (17)
Epistatic effects of ACE I/D and AGT gene variants on left ventricular mass in hypertensive patients: The HyperGEN Study (2011) (17)
A Population Association Study of Angiotensinogen Polymorphisms and Haplotypes With Left Ventricular Phenotypes (2005) (17)
Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study (2008) (17)
Echocardiographic and survival studies in mice undergoing endotoxic shock: effects of genetic ablation of inducible nitric oxide synthase and pharmacologic antagonism of platelet-activating factor. (1999) (17)
A Novel Obesity Locus on Chromosome 4q: The Strong Heart Family Study (2007) (17)
Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: The LIFE study (2011) (17)
Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study (2017) (17)
Three dimensional echocardiographic reconstruction: Experimental validation of volume measurement (1991) (16)
Linkage of left ventricular early diastolic peak filling velocity to chromosome 5 in hypertensive African Americans: the HyperGEN echocardiography study. (2002) (16)
Assessment of the interaction of heritability of volume load and left ventricular mass: the HyperGEN offspring study (2007) (16)
Regression of left ventricular hypertrophy. How and why? (1996) (16)
Factor relationships of metabolic syndrome and echocardiographic phenotypes in the HyperGEN study (2008) (16)
QTLs of factors of the metabolic syndrome and echocardiographic phenotypes: the hypertension genetic epidemiology network study (2008) (16)
Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19 (2021) (16)
Cardiovascular Disease in American Indian and Alaska Native Youth: Unique Risk Factors and Areas of Scholarly Need (2017) (16)
Fasting Insulin and Obesity-Related Phenotypes Are Linked to Chromosome 2p (2006) (15)
Relationship between left atrial volume and ischemic stroke subtype (2019) (15)
Insulin Resistance, Incident Cardiovascular Diseases, and Decreased Kidney Function Among Nondiabetic American Indians (2013) (15)
Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study. (2009) (15)
The effect of nitrous oxide on left ventricular pump performance and contractility in patients with coronary artery disease: effect of preoperative ejection fraction. (1993) (15)
Left Ventricular Mass, Brain Magnetic Resonance Imaging, and Cognitive Performance: Results From the Strong Heart Study (2017) (15)
Method errors or unexplained biological information? (2010) (15)
Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: The LIFE Study (2012) (15)
Inappropriate left ventricular mass independently predicts cardiovascular mortality in patients with type 2 diabetes. (2013) (15)
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study). (2007) (15)
Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). (2002) (15)
Prevalence and Correlates of Subclinical Atherosclerosis in Alaska Eskimos: The GOCADAN Study (2008) (15)
C-reactive protein and electrocardiographic ST-segment depression additively predict mortality: the Strong Heart Study. (2005) (15)
Racial differences in the association of coronary calcified plaque with left ventricular hypertrophy: the National Heart, Lung, and Blood Institute Family Heart Study and Hypertension Genetic Epidemiology Network. (2006) (15)
Lipoprotein-Associated Phospholipase A2 Mass and Activity and Risk of Cardiovascular Disease in a Population With High Prevalences of Obesity and Diabetes (2012) (14)
Clinical recognition and management of cardiac metastatic disease. Observations in a unique case of alveolar soft-part sarcoma. (1977) (14)
Echocardiographic predictors of intraoperative right ventricular dysfunction: a 2D and speckle tracking echocardiography study (2019) (14)
Prediction of heart failure and adverse cardiovascular events in outpatients with coronary artery disease using mitral E/A ratio in conjunction with e-wave deceleration time: the heart and soul study. (2011) (14)
The Arg16Gly polymorphism of the beta2-adrenergic receptor and left ventricular systolic function. (2003) (14)
Socioeconomic and ethnic disparities in the use of biventricular pacemakers in heart failure patients with left ventricular systolic dysfunction. (2013) (14)
Principal Component Analysis of the T Wave and Prediction of Cardiovascular Mortality in American Indians (2002) (14)
In-treatment stroke volume predicts cardiovascular risk in hypertension (2011) (14)
Echocardiographic assessment of left ventricular hypertrophy in rats using a simplified approach. (1994) (14)
Two-dimensional echocardiographic imaging: in vitro comparison of conventional and dynamically focused annular array transducers. (1987) (14)
Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation (2015) (14)
Association Between Left Ventricular Ejection Fraction, Wall Motion Abnormality, and Embolic Stroke of Undetermined Source (2019) (14)
Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients. (2010) (14)
Does long‐term losartan‐ vs atenolol‐based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy (2006) (14)
Persistence of left ventricular hypertrophy is associated with increased cardiovascular morbidity and mortality in hypertensive patients with lower achieved systolic pressure during antihypertensive treatment (2014) (14)
Multiplanar strain quantification for assessment of right ventricular dysfunction and non-ischemic fibrosis among patients with ischemic mitral regurgitation (2017) (14)
Aortic dilatation in children with systemic hypertension. (2014) (14)
Differences in risk factors for coronary heart disease among diabetic and nondiabetic individuals from a population with high rates of diabetes: the Strong Heart Study. (2012) (14)
Prevalence and correlates of rheumatic heart disease in American Indians (the Strong Heart Study). (2003) (14)
Relation of left ventricular hypertrophy, afterload, and contractility to left ventricular performance in Goldblatt hypertension. (1992) (14)
Endothelial dysfunction in resistance arteries is related to high blood pressure and circulating low density lipoproteins in previously treated hypertension. (2001) (13)
Assessment of cardiac hemodynamics and valvular function by Doppler echocardiography. (1987) (13)
Association of Hemoglobin Delivery With Left Ventricular Structure and Function in Hypertensive Patients: Losartan Intervention For End Point Reduction in Hypertension Study (2006) (13)
Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study. (2012) (13)
Blood DNA Methylation and Incident Coronary Heart Disease: Evidence From the Strong Heart Study. (2021) (13)
Regression of left ventricular hypertrophy after treatment of hypertension: comparison of directed M-echocardiography with magnetic resonance imaging in quantification of serial mass changes. (2003) (13)
Duration of ejection in aortic stenosis: effect of stroke volume and pressure gradient. (1984) (13)
Prevalence of smoking and its relationship with carotid atherosclerosis in Alaskan Eskimos of the Norton Sound region: the GOCADAN study. (2008) (13)
Systolic Blood Pressure Control and Mortality After Stroke in Hypertensive Patients (2015) (13)
Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study (2012) (12)
The influence of dietary salt and plasma renin activity on myosin heavy chain gene expression in rat hearts. (1993) (12)
Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study. (2002) (12)
Effect of body weight changes on changes in ambulatory and standardized non-physician blood pressures over three years. (1999) (12)
Lipid Treatment Goals Achieved in Patients Treated With Statin Drugs in Norwegian General Practice (2000) (12)
Hypertension research. Echocardiography in the measurement of left ventricular wall mass. (1987) (12)
Left ventricular wall stresses and wall stress–mass–heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study (2000) (12)
High Left Ventricular Mass Ambulatory Blood Pressure and M ; etabolic Abnormalities in Hypertensive Subjects With (1999) (12)
'Silent ischemia,' ventricular arrhythmias, and complications of hypertension. (1992) (12)
Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study. (2015) (12)
Identification of a pleiotropic locus on chromosome 7q for a composite left ventricular wall thickness factor and body mass index: the HyperGEN Study (2009) (12)
Hypertension treatment patterns in American Indians: the strong heart study. (2001) (12)
Noninvasive cardiology abstractRelationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study☆ (2002) (11)
Evaluation of left ventricular hypertrophy by M-mode echocardiography in patients and experimental animals. (1994) (11)
Association of low-moderate urine arsenic and QT interval: Cross-sectional and longitudinal evidence from the Strong Heart Study. (2018) (11)
Ischemia-Mediated Dysfunction in Subpapillary Myocardium as a Marker of Functional Mitral Regurgitation. (2021) (11)
Short-Term Risk of Ischemic Stroke After Detection of Left Ventricular Thrombus on Cardiac Magnetic Resonance Imaging. (2019) (11)
Bicuspid and unicuspid aortic valves: Different phenotypes of the same disease? Insight from the GenTAC Registry (2017) (11)
Is echocardiography essential in the management of newly diagnosed hypertension? (2006) (11)
Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement. (2015) (11)
Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE study (2019) (11)
Assessment of Arterial Compliance by Carotid Midwall Strain-Stress Relation in Hypertension (1999) (11)
International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes. (2021) (11)
Development of novel machine learning model for right ventricular quantification on echocardiography—A multimodality validation study (2020) (11)
Is inappropriate left ventricular mass related to neurohormonal factors and/or arterial changes in hypertension? a LIFE substudy (2004) (11)
Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study) (2009) (11)
Impact of genetic insights into mendelian disease on cardiovascular clinical practice. (2011) (11)
Impact of biological aging on arterial aging in American Indians: findings from the Strong Heart Family Study (2016) (11)
Left Ventricular Systolic Dysfunction in a Biracial Sample of Hypertensive Adults (2001) (11)
An analysis of cholesterol control and statin use in the Losartan Intervention for Endpoint Reduction in Hypertension Study. (2003) (11)
Red meat consumption and cardiovascular target organ damage (from the Strong Heart Study) (2017) (10)
Pregnancy-Related Aortic Complications in Women With Marfan Syndrome. (2021) (10)
Hemodynamic and echocardiographic profiles in African American compared with White offspring of hypertensive parents: the HyperGEN study. (2014) (10)
Prosthetic aortic graft replacement of the ascending thoracic aorta alters biomechanics of the native descending aorta as assessed by transthoracic echocardiography (2020) (10)
Prediction of symptom status following mitral valve replacement for mitral regurgitation by preoperative echocardiographic measurement of the end-systolic stress to end-systolic volume ratio (1987) (10)
Gender differences in mitral valve prolapse. (1989) (10)
Tissue-based markers of right ventricular dysfunction in ischemic mitral regurgitation assessed via stress cardiac magnetic resonance and three-dimensional echocardiography (2018) (10)
Atenolol as a comparator in outcome trials in hypertension: A correct choice in the past, but not for the future? (2007) (10)
Usefulness of quantitative assessment of electrocardiographic ST depression for predicting new-onset heart failure in American Indians (from the Strong Heart Study). (2007) (10)
Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure (2007) (10)
Influence of fat-free mass on detection of appropriateness of left ventricular mass: the HyperGEN Study (2003) (10)
Midwall left ventricular performance in salt‐loaded Dahl rats: effect of AT1 angiotensin II inhibition (1995) (10)
Sex-specific associations of nutrition with hypertension and systolic blood pressure in Alaska Natives findings from the GOCADAN study (2011) (10)
Joint Associations of 61 Genetic Variants in the Nicotinic Acetylcholine Receptor Genes with Subclinical Atherosclerosis in American Indians: A Gene-Family Analysis (2013) (10)
Cine-CMR partial voxel segmentation demonstrates increased aortic stiffness among patients with Marfan syndrome. (2017) (10)
Associations of Diet Soda and Non-Caloric Artificial Sweetener Use with Markers of Glucose and Insulin Homeostasis and Incident Diabetes: the Strong Heart Family Study (2019) (10)
Is the mitral valve prolapse patient at high risk of sudden death identifiable? (1990) (10)
Valve-sparing aortic root replacement in patients with Marfan syndrome enrolled in the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions. (2014) (10)
Change in pulse pressure/stroke index in response to sustained blood pressure reduction and its impact on left ventricular mass and geometry changes: the life study. (2008) (9)
Clinical impact of ‘in-treatment’ wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study (2008) (9)
Genome-wide linkage analysis of carotid artery lumen diameter: the strong heart family study. (2013) (9)
Prognostic role of diastolic dysfunction in patients undergoing transcatheter aortic valve replacement (2020) (9)
Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy (the LIFE Study). (2005) (9)
Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study (2004) (9)
Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (2005) (9)
Left ventricular mass regression in the LIFE study: effect of previous antihypertensive treatment. (2003) (9)
Mitral valve prolapse and hyperthyroidism: effect of patient selection. (1985) (9)
Mitral valve prolapse and severe mitral regurgitation. (1988) (9)
Echocardiography‐quantified myocardial strain—a marker of global and regional infarct size that stratifies likelihood of left ventricular thrombus (2017) (9)
Saturday, May 20, 11:15 amElevated Ambulatory With Normal Clinic Blood Pressure (“White Coat Normotension”) Is Associated With Cardiac And Arterial Target Organ Damage (1995) (9)
Left ventricular geometry predicts optimal response to percutaneous mitral repair via MitraClip: Integrated assessment by two‐ and three‐dimensional echocardiography (2019) (9)
Trends in Cardiovascular Disease Morbidity and Mortality in American Indians Over 25 Years: The Strong Heart Study (2019) (9)
Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study 1–3 (2005) (9)
Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension. (2019) (9)
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Asymptomatic Aortic Stenosis (2015) (9)
Risk Factors and Prediction of Stroke in a Population with High Prevalence of Diabetes: The Strong Heart Study (2017) (9)
Relation of ultra-low frequency heart rate variability to the clinical course of chronic aortic regurgitation. (1997) (9)
Urinary tungsten and incident cardiovascular disease in the Strong Heart Study: An interaction with urinary molybdenum (2018) (8)
IMPACT OF ETIOLOGY OF PULMONARY HYPERTENSION ON POST–PROCEDURAL MANAGEMENT AND OUTCOMES IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT (2013) (8)
Exercise performance during losartan‐ or atenolol‐based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy) (2006) (8)
Differences in Echocardiographic Findings and Systemic Hemodynamics among Non-Diabetic American Indians in Different Regions (2000) (8)
Geometry-independent inclusion of basal myocardium yields improved cardiac magnetic resonance agreement with echocardiography and necropsy quantified left-ventricular mass (2013) (8)
Role of molecular imaging with positron emission tomographic in aortic aneurysms. (2017) (8)
Leukotriene haplotype × diet interaction on carotid artery hypertrophy and atherosclerosis in American Indians: the Strong Heart Family Study. (2014) (8)
Echocardiography: state of the art--1984. (1984) (8)
Differential Impacts of Blood Pressure and Lipid Lowering on Regression of Ventricular and Arterial Mass: The Stop Atherosclerosis in Native Diabetics Trial (2011) (8)
Diuretics in the LIFE study (2004) (8)
Association of Right Ventricular Pressure and Volume Overload with Non-Ischemic Septal Fibrosis on Cardiac Magnetic Resonance (2016) (8)
Prognostic significance of left ventricular hypertrophy during treatment of hypertension: The LIFE study (2003) (8)
Heart rate is associated with markers of fatty acid desaturation: the GOCADAN study (2012) (8)
Imaging of the Postsurgical Aorta in Marfan Syndrome (2018) (8)
Marfan syndrome: genetic basis and clinical manifestations. (1993) (8)
Lung function and heart disease in American Indian adults with high frequency of metabolic abnormalities (from the Strong Heart Study). (2014) (7)
Transcatheter MitraClip repair alters mitral annular geometry – device induced annular remodeling on three-dimensional echocardiography predicts therapeutic response (2019) (7)
The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium (2012) (7)
Effect of transthoracic shocks on left ventricular function. (2005) (7)
Visually determined long- and short-axis parasternal views and four- and two-chamber apical echocardiographic views do not consistently represent paired orthogonal projections (1993) (7)
Aortic Dissection Risk in Marfan Syndrome. (2020) (7)
P-376: Left ventricular mass change during treatment and outcome in hypertensive patients with left ventricular hypertrophy: the LIFE trial (2002) (7)
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension. (2002) (7)
Working group on noncoronary cardiovascular disease and exercise in women. (1992) (7)
Subclinical, hemodynamic, and echocardiographic abnormalities of high pulse pressure in hypertensive and non-hypertensive adults. (2012) (7)
Higher left ventricular mass–wall stress–heart rate product and outcome in aortic valve stenosis (2019) (7)
Circulating protein Z concentration, PROZ variants, and unexplained cerebral infarction in young and middle-aged adults (2016) (7)
The value of noninvasive measurements in hypertension. (1990) (7)
A Contemporary Review of Acute Aortic Dissection (2015) (7)
Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy. (2014) (7)
Ultrasonic techniques for the evaluation of hypertension. (1994) (7)
Lack of association between dermal arches and mitral valve prolapse: relation to anxiety. (1984) (7)
Left ventricular mass and stroke. What is the connection? (1994) (7)
Heart rate is associated with markers of fatty acid desaturation: the GOCADAN study. (2012) (7)
Differential effects of direct antagonism of AII compared to ACE inhibitors on serum potassium levels and azotemia in patients with severe congestive heart failure. (2000) (7)
Combined rest and exercise electrocardiographic repolarization findings in relation to structural and functional abnormalities in asymptomatic aortic regurgitation. (1996) (7)
Relationship of the electrocardiographic response to exercise to geometric and functional findings in aortic regurgitation. (1987) (7)
Complex ventricular arrhythmias in patients with valvular regurgitation: A potentially important, clinically overlooked phenomenon? (1982) (6)
Workshop Target Organ Consequences in Hypertension: Pathogenesis and Prevention Participants (1991) (6)
The effect of angiotensin receptor blockers for preventing atrial fibrillation (2007) (6)
Time-motion reconstruction of mitral leaflet motion from two-dimensional echocardiography in mitral valve prolapse. (1991) (6)
Echocardiographic left ventricular mass predicts risk of developing subsequent borderline hypertension (1990) (6)
Electrocardiographic and echocardiographic detection of myocardial infarction in patients with left-ventricular hypertrophy. The LIFE Study. (2007) (6)
Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation (2006) (6)
Passage of microbubbles associated with intravenous infusion into the systemic circulation in cyanotic congenital heart disease: documentation by transesophageal echocardiography. (1987) (6)
1142-183 Association of prehypertension by joint national committee 7 criteria with left ventricular structure and function: The strong heart study (2004) (6)
Pleiotropic effects on subclasses of HDL, adiposity, and glucose metabolism in adult Alaskan Eskimos (2009) (6)
Visually determined long-axis and short-axis parasternal views and four chamber and two chamber apical views do not represent paired orthogonal projections (1990) (6)
Association of mitral annular calcification and aortic valve sclerosis with left ventricular geometry and function in hypertensive adults: the hypertension genetic epidemiology network (HyperGEN) study (2004) (6)
Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study). (2014) (6)
Acute COVID-19-Associated Decrements in Left and Right Ventricular Function Predict All-Cause Mortality (2021) (6)
Long-term follow-up of patients with mitral-valve prolapse. (1986) (6)
Automated segmentation of routine cine-CMR for volumetric assessment of presence and severity of left ventricular diastolic dysfunction (2010) (6)
Left ventricular hypertrophy--good or evil? (1983) (6)
Nonobstructive coronary artery disease as detected by 64-detector row cardiac computed tomographic angiography is associated with increased left ventricular mass. (2011) (6)
Hemoglobin A 1 C , Fasting Glucose , and Cardiovascular Risk in aPopulationWith High Prevalence of Diabetes The Strong Heart Study (2011) (6)
One year of antihypertensive treatment in patients with LVH: the life study. (1999) (5)
Ambulatory monitoring of blood pressure: the importance of blood pressure during work (1984) (5)
Acute myocardial infarction quality of care: the Strong Heart Study. (2011) (5)
Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study (2010) (5)
Association of left bundle branch block with cardiovascular morbidity and mortality in hypertensive patients with left ventricle hypertrophy: the life study (2004) (5)
Mitral valve prolapse. (1985) (5)
International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes. (2021) (5)
"Natural histories" of mitral valve prolapse. Influence of patient selection on cardiovascular event rates. (2001) (5)
A genome scan for linkage with aortic root diameter in hypertensive African Americans and whites in the Hypertension Genetic Epidemiology Network (HyperGEN) study. (2005) (5)
Impact of Mitral Regurgitation Severity and Cause on Effort Tolerance–Integrated Stress Myocardial Perfusion Imaging and Echocardiographic Assessment of Patients With Known or Suspected Coronary Artery Disease Undergoing Exercise Treadmill Testing (2019) (5)
Pericardial effusion: relation of clinical echocardiographic and electrocardiographic findings. (1984) (5)
Relation of Age to Left Ventricular Structure, Function, and Systemic Hemodynamics in Normotensive and Hypertensive Employed Adults. (1992) (5)
Impact of Paravalvular Aortic Insufficiency on Left Ventricular Remodeling and Mortality after Transcatheter Aortic Valve Replacement. (2016) (5)
Transapical transcatheter aortic valve replacement in patients with or without prior coronary artery bypass graft operation (2016) (5)
Load-independent left ventricular dysfunction in hypertension: Non-invasive detection (1982) (5)
Summary: International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional, and research purposes. (2021) (5)
Left ventricular geometry and function in hypartensive patients with ECG left ventricular hypertrophy: the LIFE trial (1998) (4)
OR-33: Regression of hypertensive left ventricular hypertrophy by angiotensin receptor blockade versus beta-blockade: the LIFE trial (2002) (4)
Comparison of left ventricular geometry and mass between black and white essential hypertensive patients (1991) (4)
Lack of association between mitral valve prolapse and history of rheumatic fever. (1996) (4)
Relations of left ventricular geometry and function to prognosis in hypertension. (1997) (4)
Myocardial perfusion pattern for stratification of ischemic mitral regurgitation response to percutaneous coronary intervention (2015) (4)
Abstract 5533: Gender Differences in Outcome During Antihypertensive Therapy in Relation to Regression of Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study (2009) (4)
Regional Heterogeneity in 3D Myocardial Shortening in Hypertensive Left Ventricular Hypertrophy: A Cardiovascular CMR Tagging Substudy to the Life Study (2015) (4)
Abstract 3203: Association of Markers of Inflammation with New-Onset Atrial Fibrillation in a Population-Based Sample: The Strong Heart Study (2006) (4)
Abstract 490: Vertebral Artery Tortuosity Index is a Novel Biomarker of Surgery and Aortic Dissection or Rupture in Children and Young Adults: Findings From the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (2014) (4)
Blood pressure normalization is associated with normal left ventricular mass but not carotid geometry: the ICARe Dicomano Study (2006) (4)
Association of echocardiographic aortic root dilatation with aortic dissection: A case control study (2003) (4)
Relationship of diastolic function to new or persistent electrocardiographic left ventricular hypertrophy (2016) (4)
812-4 Serum uric acid and ischemic stroke risk among hypertensive patients with left ventricular hypertrophy: The losartan intervention for endpoint reduction in hypertension (LIFE) study (2004) (4)
OR-27: The interaction between aspirin and losartan on cardiovascular morbidity and mortality in patients with hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) substudy (2003) (4)
Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy (2011) (4)
Comparison of Effects on Left Ventricular Filling Pressure of Intravenous Nesiritide and High-Dose Nitroglycerin in Patients With Decompensated Heart Failure (2004) (4)
The relationship of all-cause mortality to average on-treatment systolic blood pressure is significantly related to baseline systolic blood pressure: implications for interpretation of the Systolic Blood Pressure Intervention Trial study (2017) (4)
Relation of arterial and cardiac changes in normal and hypertensive adults (1991) (4)
Doctors abroad and at home: American medical education in 1981. (1981) (4)
observer variability in M-mode echocardiographic diagnosis of mitral valve prolapse: effect of tracing quality and depth of prolapse (1987) (4)
HIV-Associated Myocardial Diastolic Dysfunction and Soluble ST2 Concentration in Tanzanian Adults: A Cross-Sectional Study. (2020) (3)
Left ventricular mass as an indicator of hemodynamic load in hypertension. (1991) (3)
Epidemiology of left ventricular hypertrophy and dilated cardiomyopathy (2005) (3)
Abstract 6203: Central Pulse Pressure >=50 mmHg Predicts Adverse Cardiovascular Outcome: The Strong Heart Study (2008) (3)
Impact of paravalvular leak on left ventricular remodeling and global longitudinal strain 1 year after transcatheter aortic valve replacement. (2020) (3)
Low to Moderate Arsenic Exposure and Incident Cardiovascular Disease: The Strong Heart Study (2013) (3)
Clinical features of mitral valve prolapse associated with low body weight. (1988) (3)
Papillary muscle infarction in relation to left ventricular infarct distribution and transmurality - assessment by delayed enhancement cardiac magnetic resonance imaging (2012) (3)
Summary: international consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. (2021) (3)
Gender differences in regression of electrocardiographic left ventricular hypertrophy in response to antihypertensive therapy: The LIFE study (2003) (3)
Aortic valve sclerosis, hemodynamics, and cardiovascular risk in hypertension: a LIFE substudy (2002) (3)
Abstract 12308: Aortic Aneurysm Associated With Bicuspid Aortic Valve: Relation to Gender, Hemodynamics, and Valve Morphology: The NHLBI GenTAC Registry (2015) (3)
888-3 Racial differences in the prognostic value of the electrocardiographic strain pattern in hypertensive patients: The LIFE study (2004) (3)
Echocardiography, hypertension, and left ventricular mass. (1988) (3)
CARDIOVASCULAR COMPLICATIONS IN RELATION TO THE FRAMINGHAM RISK SCORE AND AGE IN HYPERTENSIVE PATIENTS WITH LVH: THE LIFE STUDY (2000) (3)
Editorial note Antihypertensive treatment and regression of left ventricular hypertrophy (1984) (3)
On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy (2020) (3)
Comparison of the SCOPE and LIFE results. (2003) (3)
Regression of left ventricular hypertrophy: lodestar to stroke prevention in the treatment of hypertension? (2006) (3)
Left ventricular geometry and cardiac risk factors define high and low risk subgroups among essential hypertensives (1990) (3)
Does aortic valve sclerosis predict cardiovascular events independently of albuminuria in hypertension? A LIFE study (2003) (3)
Electrocardiographic detection of concentric and eccentric left ventricular hypertrophy (1986) (3)
Transesophageal echocardiography and risk of respiratory failure in patients who had ischemic stroke or transient ischemic attack: an IDEAL phase 4 study (2022) (3)
Echocardiographic assessment of left ventricular outflow obstruction. (1978) (3)
Regression of echocardiographic left ventricular hypertrophy in relation to resolution versus persistence of electrocardiographic strain after one year of antihypertensive therapy The LIFE study (2002) (3)
Coronary Artery Disease and Cardiomyopathy (2010) (3)
Heritability of Carotid Artery Structure and Function (2002) (3)
Fibrinogen and Preclinical Echocardiographic Target Organ Damage (2001) (3)
Cardiovascular damage in obesity and metabolic syndrome. (2011) (2)
SUDDEN CARDIAC DEATH IN RELATION TO CHANGING HEART RATE DURING TREATMENT OF HYPERTENSION: THE LIFE STUDY (2010) (2)
781-4 Relation of Pulse Pressure to Target Organ Damage in Hypertensive Patients (1995) (2)
Mitral apparatus assessment by delayed enhancement CMR - relative impact of papillary muscle and left ventricular wall infarction on ischemic mitral regurgitation (2012) (2)
Abstract 1881: Association of New-Onset Left Bundle Branch Block with Cardiovascular Morbidity and Mortality in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE study (2006) (2)
Questions regarding the aortic measurements of Mitchell et al. (2008) (2)
Relation of panic attacks and midsystolic murmurs to over-diagnosis of mitral valve prolapse (1994) (2)
What is bright is not always gold. (2003) (2)
Fasting Plasma Glucose and Hemoglobin A 1c in Identifying and Predicting (2011) (2)
TWO-DIMENSIONAL ECHOCARDIOGRAPHIC AORTIC ROOT DIMENSIONS IN ADOLESCENTS AND ADULTS: NORMAL LIMITS IN RELATION TO AGE, BODY SIZE AND GENDER (2010) (2)
Abstract 2995: Impact of Atenolol versus Losartan-Based Treatment on Aortic Root Dilatation in Hypertension: The LIFE Study (2006) (2)
PERSISTENCE OF LEFT VENTRICULAR HYPERTROPHY IS ASSOCIATED WITH MARKEDLY WORSE OUTCOMES IN PATIENTS WITH LOWER ACHIEVED SYSTOLIC PRESSURE (?130 MM HG) DURING ANTIHYPERTENSIVE TREATMENT: THE LIFE STUDY (2011) (2)
B018: Age-dependent event rate and reduction of coronary risk in hypertensive patients with LVH: The life study (2000) (2)
Hypertension, cardiac hypertrophy and the effects of anaesthesia (1997) (2)
Diuretics in the LIFE study - Reply (2004) (2)
Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients. the life study (2013) (2)
Abstract 4421: Concomitant Hydrochlorothiazide Therapy in Hypertensive Patients is Associated with Reduced Cardiovascular Morbidity and Mortality Independent of Blood Pressure and Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study (2008) (2)
Exercise-induced ischemia and carotid atherosclerosis. (1999) (2)
Abstract 3681: Diabetes And Incident Congestive Heart Failure (2007) (2)
More on Munchausen Syndrome (1974) (2)
Angiotensin converting enzyme inhibition of renin system activity induces reversal of hypertensive target organ changes. Do these effects predict a reduction in long-term morbidity? (1992) (2)
Assessing Left Ventricular Performance: A Rashomon Effect (2008) (2)
Aortic Valve Area in Aortic Stenosis: A Network Meta-Analysis. (2020) (2)
Performance of Dynamic Automated CT Annular Measurements Compared to Standard Manual Measurements for Transcatheter Aortic Valve Replacement Sizing. (2019) (2)
Abstract 1654: Prevalence and Correlates of Aortic Root Dilatation in Normotensive and Hypertensive Adults: The Family Blood Pressure Program (2009) (2)
Lack of association between acute myocardial infarction and mitral valve prolapse. (1988) (2)
DEVELOPMENT OF A NOVEL DEEP LEARNING MODEL FOR RIGHT VENTRICULAR QUANTIFICATION ON ECHOCARDIOGRAPHY: A MULTIMODALITY VALIDATION STUDY (2019) (2)
Bioprosthetic mitral valve paravalvular leak closure using intracardiac echocardiography‐guided three dimensional electroanatomic mapping (2018) (2)
Descending aortic strain quantification by intra‐operative transesophageal echocardiography: Multimodality validation via cardiovascular magnetic resonance (2020) (2)
Survival after valve replacement for aortic regurgitation: Prediction from noninvasive contractility measurement and comparison with census-expected survival (2003) (2)
Comparing Vascular Brain Injury and Stroke by Cranial Magnetic Resonance Imaging, Physician-Adjudication, and Self-Report: Data from the Strong Heart Study (2021) (2)
Differences in echocardiographic findings and systemic hemodynamics among non-diabetic American Indians in different regions: The Strong Heart Study. (1998) (2)
Pharmacologic stress echocardiography. (1992) (2)
Electrocardiogram R wave amplitude changes during exercise : relation to left ventricular volume changes (1991) (2)
Association Between Cervical Artery Dissection and Aortic Dissection. (2021) (2)
The effect of losartan versus atenolol on aortic valve sclerosis: A LIFE study (2003) (2)
[Ventricular systolic function. The intramyocardial mechanics and the indices of systolic ejection: the different physiological and clinical significance]. (1998) (1)
1163-111 Myocardial performance index independently predicts cardiovascular morbidity and mortality in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study (2004) (1)
Abstract 121: Machine Learning Prediction of Stroke Mechanism in Embolic Strokes of Undetermined Source (2019) (1)
Impact of achieved systolic blood pressure on renal function in hypertensive patients. (2016) (1)
Pediatric and Adolescent Heart Disease Impact of Obesity on Cardiac Geometry and Function in a Population of Adolescents The Strong Heart Study (2006) (1)
Large Cohort Data Based Group or Community Disease Prevention Design Strategy: Strong Heart Study (2018) (1)
Are NT-Pro brain natriuretic peptides related to systolic and diastolic left ventricular function at baseline and during antihypertensive treatment? The LIFE study (2003) (1)
Prognostic implications of left ventricular (2001) (1)
910-16 Ventricular Size and Function Early and Late After Mitral Valve Repair vs Mitral Valve Replacement for Mitral Regurgitation (1995) (1)
Abstract 297: Prevalence, Predictors, and Functional Consequences of Sub-Clinical Papillary Muscle Infarction Following Acute Myocardial Infarction (2009) (1)
Three-Dimensional (3D) Acquisition and Display of Beating Heart Echo Images (1993) (1)
N-terminal pro-brain natriuretic peptide predicts cardiovascular events in hypertension: A LIFE substudy (2003) (1)
Association of Left Ventricular Hypertrophy Regression and Heart Rate Reduction With Determinants of Myocardial Oxygen Consumption and Cardiovascular Events: The LIFE Study (2003) (1)
OR-21: Relation of serum uric acid to cardiovascular endpoints in hypertension: the life study (2003) (1)
, Kurt Study Stroke in Patients With Aortic Stenosis : The Simvastatin and Ezetimibe in Aortic Stenosis (1)
Differential Effects of Aortic Valve Replacement on Aortic Circumferential Strain in Aortic Stenosis and Aortic Insufficiency. (2020) (1)
1908-P: Factors Related to Hepatic Fat and Fibrosis in American Indians (2019) (1)
THE NEED FOR STANDARDIZED METHODS FOR MEASURING THE AORTA: EXPERIENCE FROM THE NATIONAL REGISTRY OF GENETICALLY TRIGGERED THORACIC AORTIC ANEURYSMS (GENTAC) (2014) (1)
Evidence for marked disproportionate myocardial dysfunction in the septum in hypertensive left ventricular hypertrophy (1998) (1)
A033: Impact of antihypertensive treatment on left ventricular geometric patterns: The preserve study (2000) (1)
Abstract 3150: Left Ventricular Structure in Different Types of Chronic Pressure-Overload (2006) (1)
Abstract 3668: Predictors of Four-Year Incident Arterial Hypertension From Initial Prehypertension: The Strong Heart Study. (2007) (1)
Abstract 13178: Bicuspid Aortic Valve and Marfan Syndrome: Two Strikes? (2013) (1)
Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study (2010) (1)
Long term effects of hypertension on the heart (1980) (1)
Left Ventricular Hypertrophy Regression and Atrial Fibrillation Incidence—Reply (2007) (1)
Summary: International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes. (2021) (1)
Adducin 1 (alpha) Gly460Trp variant is associated with left ventricular geometry in Caucasians and African Americans: The HyperGEN Study. (2010) (1)
Abstract 2184: Glycemic Level and Future Stroke in Type 2 Diabetes Mellitus: The Strong Heart Study. (2006) (1)
Electrocardiographic measures of heterogeneity of ventricular repolarization (1998) (1)
[OP.4A.09] THE RELATIONSHIP OF ALL-CAUSE MORTALITY TO AVERAGE ON-TREATMENT SYSTOLIC BP IS RELATED TO BASELINE SYSTOLIC BP: IMPLICATIONS FOR INTERPRETATION OF THE SPRINT STUDY (2017) (1)
Left Ventricular Mass as a Measure of Preclinical Disease in Patients with Hypertension (1992) (1)
Primary Prevention of Atrial Fibrillation in Hypertensive Patients: What Is New from the LIFE Trial? (2006) (1)
QRS voltage-duration product: Electrocardiographic detection of left ventricular hypertrophy (1991) (1)
Abstract 16357: Prevalence of Left Ventricular Thrombus (LVT) One Month Post Myocardial Infarction in Patients Discharged With Negative Inpatient Echocardiography - Incremental Utility of Delayed Enhancement Cardiac Magnetic Resonance (DE-CMR) Tissue Characterization (2014) (1)
Impact of left ventricular structural and functional abnormalities on prognosis in a population-based sample of coronary heart disease-free older adults with renal insufficiency: The strong heart study (2003) (1)
Antihypertensive therapy has greater impact on left ventricular hypertrophy reduction in women than men: The life study (2000) (1)
THE IMPORTANCE OF BLOOD PRESSURE VARIABILITY FOR SUBCLINICAL ORGAN DAMAGE AND CARDIOVASCULAR EVENTS. A LIFE SUBSTUDY: 8C.07 (2010) (1)
P-374: Differences in heart rate variabilty in African-American vs Caucasian hypertensives with left ventricualr hypertrophy: the LIFE study (2002) (1)
888-2 Does left ventricular hypertrophy predict sudden cardiac death independent of ischemia? The LIFE study (2004) (1)
Abstract 8654: Low In-Treatment HDL Cholesterol Levels Strongly Predict New Heart Failure in Hypertensive Patients: The LIFE Study (2011) (1)
Abstract 9371: Low In-Treatment HDL Cholesterol Strongly Predicts Incident Atrial Fibrillation: The LIFE Study (2012) (1)
P-50: Similarities and differences among patients with isolated systolic or combined systolic diastolic hypertension: The life study (2001) (1)
1009-166 Pulse pressure as cardiovascular risk marker during losartan or atenolol based therapy in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE trial) (2004) (1)
Modified Pooled Cohort Atherosclerotic Cardiovascular Disease Risk Prediction Equations in American Indians (2020) (1)
Cardiovascular Outcome: The Strong Heart Study High Central Pulse Pressure Is Independently Associated With Adverse (2011) (1)
DIFFERENT APPROACHES TO LEFT ATRIAL VOLUME INDEXATION AND RISK OF CARDIOVASCULAR DISEASE AND DEATH IN A POPULATION WITH HIGH PREVALENCE OF OBESITY: THE STRONG HEART STUDY (2016) (1)
Abstract 2591: Association of Left Ventricular Mass and Ejection Fraction with New-Onset Atrial Fibrillation in a Population-Based Sample: The Strong Heart Study (2006) (1)
Electrocardiographic strain pattern and the prediction of cardiovascular morbidity and mortality in hypertensive patients: The LIFE study (2003) (1)
Abstract 2635: Prothrombotic Disorders, Patent Foramen Ovale and Unexplained Cerebral Infarction: The THrombophilia in Cryptogenic StroKe (THICK) Study (2008) (1)
The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study (2006) (1)
Intracardiac thrombi in patients undergoing electroconvulsive therapy. (1990) (1)
Abstract 9749: Impact of QRS Duration and Morphology on The Risk of Sudden Cardiac Death in Asymptomatic Patients with Aortic Stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis Study (2011) (1)
from A / J Mice Treated with Nitrosamines Protooncogene in Lung Tumors ras and the Activation of the K-Relationship between the Formation of Promutagenic Adducts (2006) (1)
Arterial stiffness and left ventricular geometry and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study (2002) (1)
Abstract 1449: Racial Differences in Incident Heart Failure Among Hypertensive Patients During Antihypertensive Therapy: The LIFE Study (2009) (1)
A pairwise meta-analytic comparison of aortic valve area determined by planimetric versus hemodynamic methods in aortic stenosis. (2020) (1)
Mitral Valve Prolapse (1976) (1)
Risk, recognition, and reversal of left ventricular hypertrophy in hypertension (1991) (1)
EFFECT OF MIDAZOLAM ON CARDIAC PUMP PERFORMANCE AND CONTRACTILITY (1991) (1)
RACIAL DIFFERENCES IN SUDDEN CARDIAC DEATH AMONG HYPERTENSIVE PATIENTS DURING ANTIHYPERTENSIVE THERAPY: THE LIFE STUDY (2011) (1)
Genetic Loci In fl uencing Myocardial Mass (2016) (1)
Masking of echocardiographic mitral valve prolapse during evolution of dilated cardiomyopathy. (1993) (1)
Diuretics in the LIFE study. Authors' reply (2004) (1)
1142-179 Body fat distribution influences cardiac output in normotensive and hypertensive overweight individuals: The hyperGEN study (2004) (1)
Association of left bundle branch block with new onset abnormal wall motion in treated hypertensive patients with left ventricle hypertrophy: the LIFE Echo Sub-study (2019) (1)
Incremental Value of Echocardiography in Patients With or Without Hypertension: Which (Death)Star to Hitch the Wagon? (2018) (1)
The relative importance of central and brachial blood pressure in predicting cardiovascular events: an individual participant meta-analysis of prospective observational data from 22,433 subjects (2016) (1)
Left ventricular global longitudinal strain and cardiac surgical outcomes. (2020) (1)
Large Cohort Data Based Cost-Effective Disease Prevention Design Strategy: Strong Heart Study (2018) (1)
Is urinary albumin excretion an independent predictor of cardiovascular mortality in patients with electrocardiographic left ventricular hypertrophy? The LIFE study (2002) (1)
Abstract 2979: Association of Aortic Annular Dilatation With Aortic Regurgitation in Patients With Thoracic Aneurysms: The GenTAC Registry (2009) (1)
CARDIAC REMODELING AND DIASTOLIC DYSFUNCTION PRECEDE NON MI-RELATED HEART FAILURE IN HIGH-RISK HYPERTENSIVE PATIENTS: THE LIFE ECHO SUBSTUDY. (2010) (1)
Differential myocardial strain in the early postoperative period in patients receiving arterial vs venous bypass grafts: A hypothesis‐generating study (2020) (1)
Marked variability in published CMR criteria for left ventricular basal slice selection - impact of methodological discrepancies on LV mass quantification (2013) (1)
O-30: Predictors of cardiovascular events in 9,194 hypertensive patients with left ventricular hypertrophy. The LIFE study* (2001) (1)
P-398: Systolic left ventricular function improves more by beta-blokade than losartan: the life study (2003) (1)
The effect of midazolam on cardiac pump performance and contractility in patients with coronary artery disease (1992) (1)
Does left ventricular hypertrophy predict sudden cardiac death independent of ischemia (2004) (1)
C14The Association Of Carotid Atherosclerosis With Electrocardiographic Myocardial Ischemia And Left Ventricular Hypertrophy (1995) (1)
Impact of ascending aortic prosthetic grafts on early postoperative descending aortic biomechanics on cardiac magnetic resonance imaging. (2021) (1)
A Point System Table to Estimate the Risk of Cardiovascular Events in Patients with Hypertension and Left Ventricular Hypertrophy: The LIFE Study (2021) (1)
4.20 Clinical Impact of Changes in Wall Motion Abnormalities in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study (2007) (0)
Abstract 14983: Arterial Tortuosity and Cardiovascular Outcomes in Marfan Syndrome and Loeys-Dietz Syndrome (2016) (0)
33. High salt intake and blood viscosity increase the risk of cardiovascular morbidity in arterial hypertension: a follow-up study (1991) (0)
Left Ventricular Systolic Function in Hypertensive Patients with ECG Determined Left Ventricular Hypertrophy: The Life Study (1998) (0)
Cardiac and Vascular Remodeling in Older Adults With Borderline Isolated Systolic Hypertension (2001) (0)
Abstract 717: Utility of Biochemical and Echocardiographic Measures of Subclinical Organ Damage in Risk Prediction for First Ischemic Stroke: The Strong Heart Study (2009) (0)
Hypertrophic Cardiomyopathy (2019) (0)
Abstract 3637: Influence of Non-Hemodynamic Factors on Left Ventricular Mass in Adolescents with High Prevalence of Obesity: the Strong Heart Study. (2007) (0)
Abstract 11516: Non-Ischemic Fibrosis as a Marker of Adverse Right Ventricular Remodeling - A Multimodality Imaging Study (2015) (0)
The influence of dietary salt on myosin heavy chain gene expression in rat hearts (1991) (0)
IMPACT OF MYOCARDIAL MID WALL FIBROSIS AND CHAMBER REMODELING ON LEFT VENTRICULAR WALL STRESS AS QUANTIFIED BY CARDIAC MAGNETIC RESONANCE (CMR) IMAGING (2014) (0)
’ s response to reviews Title : Echocardiographic Predictors of Intraoperative Right Ventricular Dysfunction : A 2 D and Speckle Tracking Echocardiography Study (2019) (0)
Loop Diuretic Absorption (2000) (0)
Abstract 13304: Prevalence, Perfusion-Based Markers, and Exercise Manifestations of Right Ventricular Dysfunction Among 2,051 Consecutive Patients Undergoing Exercise Myocardial Perfusion Imaging (2016) (0)
Oral Sessions (2014) (0)
ASSOCIATION OF 12-LEAD ECG ABNORMALITIES WITH CARDIOVASCULAR EVENT RATES IN AORTIC STENOSIS: THE SIMVASTATIN AND EZETIMIBE IN AORTIC STENOSIS STUDY (2014) (0)
Mitral Valve Prolapse: Clinically Relevant Aspects (1998) (0)
Abstract 4058: A longitudinal Study of Risk Factors for the Incident Abnormal Albuminuria in Diabetic American Indians: The Strong Heart Study (2006) (0)
Abstract 9245: Incident Atrial Fibrillation is Associated with an Increased Risk of Sudden Cardiac Death in Hypertensive Patients During Antihypertensive Therapy: The LIFE Study (2011) (0)
Abstract 15436: Transverse Right Ventricular Strain - Initial Validation of a Novel Echocardiographic Functional Index in Comparison to Cardiac Magnetic Resonance (2017) (0)
Abstract 12734: A New 4-group Classification of Left Ventricular Hypertrophy Based on left Ventricular Geometry Located a New High-risk Group within Eccentric Hypertrophy in Hypertensive Patients - A LIFE Study (2012) (0)
Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment in patients with electrocardiographic left ventricular hypertrophy (LIFE) (2013) (0)
Routine cine-CMR segmentation via a novel automated algorithm (LV-METRIC) for assessment of aortic physiology: a clinical validation study (2015) (0)
Unselected Geriatric Population: The ICARe Dicomano Study Central But Not Brachial Blood Pressure Predicts Cardiovascular Events in an (2011) (0)
Abstract 9398: Cornell Product Criteria for Left Ventricular Hypertrophy Strongly Predicts the Presence of Diastolic Dysfunction (2012) (0)
P-Reactive Protein and Electrocardiographic T-Segment Depression Additively Predict Mortality (2016) (0)
901-80 Auscultatory Gaps and Target Organ Damage in Hypertensive Patients (1995) (0)
Abstract 4039: Preclinical Cardiac Disease and Outcome in Adults with Kidney Disease: The Strong Heart Study (2006) (0)
DataBase: Research and Evaluation Results (1991) (0)
Electrocardiographic strain pattern and albuminuria : Additively predict new-onset congestive heart failure in hypertension patients. The LIFE study (2005) (0)
Preface (1973) (0)
A NEW FOUR-GROUP CLASSIFICATION OF LEFT VENTRICULAR HYPERTROPHY BASED ON LEFT VENTRICULAR GEOMETRY LOCATED A NEW HIGH-RISK GROUP WITHIN ECCENTRIC HYPERTROPHY IN A POPULATION-BASED STUDY: THE STRONG HEART STUDY (2013) (0)
Gender differences in the electrocardiogram and fat free mass: the strong heart study (2002) (0)
RELATIONSHIP OF INCIDENT ATRIAL FIBRILLATION TO RENAL FUNCTION IN HYPERTENSIVE PATIENTS WITH ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY: THE LIFE STUDY (2014) (0)
INCREMENTAL VALUE OF RIGHT VENTRICULAR STRAIN AND 3D ECHO COMPARED TO CONVENTIONAL ECHO APPROACHES FOR DETECTION OF CARDIAC MRI (CMR) EVIDENCED RIGHT VENTRICULAR DYSFUNCTION IN ISCHEMIC MITRAL REGURGITATION (2018) (0)
Hypertension and the heart. Advances in experimental medicine and biology (1997) (0)
P-515: ATPIII-defined metabolic syndrome is associated with prevalence of LV hypertrophy in white, but not in African American, treated hypertensives: The hypergen study (2003) (0)
Chapter 31 – The LIFE Study (2005) (0)
Cardiovascular features and prognosis of middle-aged and elderly adults with renal dysfunction: the strong heart study (2002) (0)
VERTEBRAL ARTERY TORTUOSITY IS A BIOMARKER FOR ARTERIAL EVENTS IN CHILDREN AND YOUNG ADULTS WITH VASCULAR EHLERS-DANLOS SYNDROME (2020) (0)
P-134: Older age does not attenuate hypertrophy regression during antihypertensive treatment in hypertensive patients with left ventricular hypertrophy (the life study) (2003) (0)
Mid-wall fibrosis on delayed enhancement CMR - a marker for adverse left ventricular chamber remodeling independent of cardiomyopathic etiology (2014) (0)
A Q t L for Genotype by s ex Interaction for Anthropometric Measurements in Alaskan Eskimos (GOCADAN s tudy) on Chromosome (2011) (0)
The relationship of in-treatment serum glucose to all-cause mortality and cardiovascular morbidity and mortality in hypertensive patients without known diabetic during treatment : the LIFE study (2009) (0)
Cine-CMR quantified left atrial diameter - a simple index of left atrial remodeling that closely parallels chamber area and stratifies longitudinal atrial arrhythmic risk (2014) (0)
ADVERSE LEFT VENTRICULAR REMODELING DUE TO AORTIC INSUFFICIENCY POST TRANSCATHETER AORTIC VALVE REPLACEMENT AND DOWNSTREAM IMPACT ON ALL-CAUSE MORTALITY (2014) (0)
Midwall left ventricular performance in normotensive normal-weight children and adults (1996) (0)
A028: Regression of left ventricular hypertrophy does not improve ventricular arrhythmogenecity-six month results: A life sub-study (2000) (0)
Sensitivity of echocardiogram and electrocardiogram for detection of mild moderate and severe left ventricular hypertrophy (1985) (0)
PERIPROCEDURAL BLOOD TRANSFUSIONS IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT (2017) (0)
21.0: Multidetector coronary CT angiography for the assessment of patients with chest pain presenting to the emergency department (2007) (0)
Electrocardiographic identification of left ventricular hypertrophy using a self-learning neutral network (1991) (0)
LOWER ACHIEVED SYSTOLIC PRESSURE (≤130 MM HG) IS ASSOCIATED WITH WORSE RENAL FUNCTION BUT A SLOWER DECLINE IN GFR IN HYPERTENSIVE PATIENTS WITH ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY: THE LIFE STUDY (2014) (0)
COVID-19 ASSOCIATED DECREMENTS IN LEFT VENTRICULAR FUNCTION PREDICT MORTALITY (2021) (0)
Abstract 11359: Relationship of Incident Atrial Fibrillation to the Electrocardiographic Strain Pattern in Hypertensive Patients With Electrocardiographic Left Ventricular Hypertrophy (2016) (0)
Abstract 3416: Incremental Diagnostic Utility of Contrast-Enhanced MRI (CE-MRI) vs Contrast Echocardiography for Detection of Left Ventricular Thrombus: Morphologic Predictors of Improved Thrombus Detection by CE-MRI in Patients with Systolic Dysfunction (2007) (0)
Abstract 19411: Circulating Protein Z Levels, Variants in the Protein Z Gene and Unexplained Cerebral Infarction in Young and Middle-Aged Adults (The Thrombophilia in Cryptogenic stroke [THICK] Study) (2014) (0)
Abstract WP112: A Clinical Score To Predict Reduced Ejection Fraction In Acute Ischemic Stroke (2022) (0)
Relations of ethnicity and vascular parameters to left ventricular structure in hypertensive adults (2003) (0)
Validation of anular array technology (1990) (0)
Genetic evidence thatmutations intheCOLJAJ, COLJA2,COL3AJ,orCOLSA2collagen genesare notresponsible formitral valve prolapse (1989) (0)
Abstract 14200: The Association Between Markers of Preclinical Cardiovascular Disease and Incident Diabetes is Mediated by the Insulin Resistance Syndrome: The Strong Heart Study (2016) (0)
Ethnicity, left ventricular hypertrophy regression and cardiovascular events in the life echocardiography substudy (2004) (0)
Abstract 19272: Risk Factors and Prediction of Stroke in a Population With High Prevalence of Diabetes: The Strong Heart Study (2016) (0)
Left atrial size and risk of stroke in American Indians free of clinical cardiovascular disease (2003) (0)
Dietary intakes of Alaskan Eskimo adults of Northwest Alaska, 2000–2003: the gocadan (genetics of coronary artery disease in Alaska natives) study (2004) (0)
Is the severity of hypertension related to different cardiac features in patients with left ventricular hypertrophy? The preserve study. (1999) (0)
Relations of left ventricular hypertrophy to markers of systemic inflammation and microangiopathy in adults with type II diabetes: the strong heart study (2002) (0)
Metabolic Aspects and Mechanisms (2008) (0)
ASSOCIATION OF HIGH SERUM GLUCOSE LEVELS WITH LOW HDL CHOLESTEROL LEVELS IN NON-DIABETIC HYPERTENSIVE PATIENTS: IMPLICATIONS FOR THE DEVELOPMENT OF NEW DIABETES (2012) (0)
TISSUE-BASED MARKERS OF RIGHT VENTRICULAR DYSFUNCTION IN ISCHEMIC MITRAL REGURGITATION AS ASSESSED VIA STRESS CARDIAC MAGNETIC RESONANCE (2019) (0)
942-42 Is Mitral Valve Prolapse with Significant Mitral Regurgitation a Different Condition from Uncomplicated Mitral Prolapse? Results of Family Studies (1995) (0)
Abstract 12975: HbA1c, Glycemia, and Future Cardiovascular Events: The Strong Heart Study (2010) (0)
Abstract 5055: The SANDS Trial: Does Aggressive Lowering of LDL-C and Non-HDL-C in Diabetes Decrease the Plasma ApoB and LDL-C Particle Number? (2008) (0)
Hypertensive patients with diabetes have less regression of electrocardiographic left ventricular hypertrophy in response to antihypertensive therapy: The LIFE study (2003) (0)
OR-48: Does losartan treated patients with albuminuria have better cardiovascular outcome than those treated with atenolol? The LIFE study (2002) (0)
Association of accelerated atherosclerosis and myocardial hypertrophy with systemic lupus erythematosus (1998) (0)
A load adjusted performance index enhances prediction of temporal changes in left ventricular ejection fraction among asymptomatic patients with chronic nonischemic aortic regurgitation and initially normal resting function (2002) (0)
Is albuminuria a cardiovascular risk factor independent of left ventricular hypertrophy in hypertension? A LIFE study (2003) (0)
Diagnostic imaging of the cardiovascular system in the Marfan syndrome (1996) (0)
Abstract 10405: Carotid Plaque, Not Intimal-Medial Thickness, Predicts Clinical Cardiovascular Disease: The Strong Heart Study (2010) (0)
Is impaired fasting glucose associated with subclinical arterial disease? The strong heart study (2012) (0)
Abstract 13419: Linear Fractional Shortening on Echocardiography (Echo)- A Novel Index of Right Ventricular Systolic Dysfunction as Validated by Cardiac Magnetic Resonance (CMR) (2016) (0)
Validation of annular array technology. (1990) (0)
Introduction (2005) (0)
Abstract P297: A Pathway Analysis of 32 Genetic Variants in Leukotriene Genes and Subclinical Atherosclerosis in American Indians: The Strong Heart Family Study (2012) (0)
Expression of Aspartyl 3-Hydroxylase in Patients with Marfan Syndrome: Preliminary Findings (1999) (0)
High Cardiac Output Is Correlated with Increased Myocardial Wall Stress and Brain Natriuretic Peptide in Patients with Chronic Kidney Disease on Hemodialysis (2007) (0)
Abstract 9903: Baseline Left Atrial Abnormality by Electrocardiogram Predicts Incident Stroke in Hypertensive Patients With Electrocardiographic Left Ventricular Hypertrophy (2015) (0)
Abstract 15018: Incremental Prognostic Utility of Adverse Right Ventricular Remodeling in Patients With Covid-19 Infection: A Multicenter Cohort Study (2020) (0)
Abstract 1833: Relationship of Left Atrial Enlargement to Persistence or Development of Electrocardiographic Left Ventricular Hypertrophy in Hypertensive Patients: Implications for the Development of New Atrial Fibrillation (2006) (0)
ETIOLOGY AND DOWNSTREAM HEMODYNAMIC IMPACT OF PULMONARY HYPERTENSION IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT (2013) (0)
Abstract 16803: Gender Differences in the Impact of Arterial Stiffness on Outcome in Hypertensive Patient With Left Ventricular Hypertrophy (The Life Study) (2013) (0)
Abstract WP264: Relationship between Left Atrial Volume and Ischemic Stroke Subtype (2019) (0)
928-78 Electrocardiographic Identification of Left Ventricular Hypertrophy: Test Performance and Variability in Relation to Definition of Hypertrophy (1995) (0)
31. Predictors of left ventricular hypertrophy in arterial hypertension: a major role for overweight and salt intake (1991) (0)
DOES INTRA-AORTIC BALLOON PUMP PLACEMENT DURING HOSPITALIZATION COURSE FOR TRANSCATHETER AORTIC VALVE REPLACEMENT PORTENT A WORSE CLINICAL OUTCOME? (2017) (0)
Abstract 10213: Digoxin Use and Risk of Mortality in Hypertensive Patients With Atrial Fibrillation: The LIFE Study (2013) (0)
Novel Echocardiographic Algorithm for Right Ventricular Mass Quantification - Cardiovascular Magnetic Resonance and Clinical Prognosis Validation. (2021) (0)
Comment Is the Electrocardiogram Still Useful for Detection of Left Ventricular Hypertrophy ? (2005) (0)
1112-149 Does use of harmonic imaging increase the yield of echocardiographic left ventricular mass measurements on a population basis? The strong heart study (2004) (0)
Structural abnormalities defined by three-dimensional echocardiography in patients with right ventricular tachycardia (1998) (0)
Radionuclide-based selection for mitral surgery in high risk patients with non-ischemic mitral regurgitation (1997) (0)
Inappropriate Left Ventricular Mass and Ambulatory Blood Pressure in Arterial Hypertension (1998) (0)
Evolution of left ventricular filling pattern among American Indians: The strong heart study (2003) (0)
Abstract 2338: Prevalence and Prognostic Significance of Wall Motion Abnormalities in Adults without Recognized Cardiovascular disease: The Strong Heart Study (2006) (0)
Hypertension and left ventricular hypertrophy: a consideration of current antihypertensive therapies (1994) (0)
Abstract 9358: Time-Course of Left Ventricular Geometry in Arterial Hypertension: The Strong Heart Study (2011) (0)
LEFT VENTRICULAR CHAMBER DILATION PREDICTS THERAPEUTIC RESPONSE TO MITRACLIP: IMPACT OF ADVERSE LV REMODELING ON MITRAL REGURGITATION RECURRENCE FOLLOWING PERCUTANEOUS REPAIR (2018) (0)
975-81 Prognostic Value of Ultra-Low Frequency Heart Rate Variability in Chronic Aortic Regurgitation (1995) (0)
Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients (2019) (0)
OR 68: Left ventricular structure and function predict clinical cardiovascular risk in prehypertension: The strong heart study (2004) (0)
A068: White coat hypertension in patients with ECG determined left ventricular hypertrophy: The LIFE study (1999) (0)
Abstract 3020: Established MRI Methods for Ejection Fraction and Myocardial Mass Quantification Produce Significantly Different Results Based on Trabecular and Papillary Volumes: Effects on Clinical Standards in Heart Failure (2006) (0)
Abstract 2281: Mitral E Wave Deceleration Time to Peak E Velocity Ratio And Cardiovascular Outcome in Hypertensive Patients During Anti-Hypertensive Treatment: the LIFE Echo-Substudy. (2007) (0)
C‐Reactive Protein, Fibrinogen, and Incident Heart Failure in the Strong Heart Study Population (2013) (0)
Abstract P388: Novel Metabolic Markers for the Risk of Carotid Plaque Progression in American Indians (2015) (0)
Abstract 4157: Do Left Ventricular Hypertrophy and Systolic Dysfunction Represent Sequential Steps in the Pathway to Heart Failure (The Strong Heart Study)? (2006) (0)
The cardiac and hemodynamic effects of insulin on non-diabetic American Indians: the strong heart study (1998) (0)
Abstract 2757: Development of New Electrocardiographic Strain Pattern is Associated With an Increased Risk of Cardiovascular Morbidity and Mortality During Antihypertensive Treatment: The LIFE Study (2006) (0)
Left ventricular disstolic function in hypertensive patients with ecg determined left ventricular hypertrophy: the LIFE study (1998) (0)
Abstract 15129: Outcomes Related to Age of Elective Surgery and Age of Dissection Within Genetically Triggered Aneurysm Conditions: The Gentac Experience (2020) (0)
LEFT VENTRICULAR REMODELING FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT IS MORE FAVORABLE IN PATIENTS WITH NO SIGNIFICANT PARAVALVULAR AORTIC REGURGITATION VERSUS THOSE WITH MILD PARAVALVULAR AORTIC REGURGITATION (2013) (0)
Aortic Dilatation Associated with Bicuspid Aortic Valve: Relation to Sex, Hemodynamics, and Valve Morphology (The NHLBI GenTAC Registry) (2017) (0)
Abstract 3617: The Relation of New Atrial Fibrillation to Cardiovascular and All-Cause Mortality During Treatment of Hypertension: The LIFE Study (2007) (0)
Abstract 9572: Post-Stenotic Dilatation in Asymptomatic Aortic Stenosis (2011) (0)
LOWER AVERAGE SYSTOLIC PRESSURE (<140 MM HG) IS NOT ASSOCIATED WITH IMPROVED OUTCOMES IN HYPERTENSIVE PATIENTS WITH ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY AGED 60 OR GREATER: FINDINGS IN SUPPORT OF THE JNC-8 RECOMMENDATIONS (2015) (0)
Response to Gender Differences in Left Ventricular Hypertrophy Regression (2008) (0)
Competing effects of hypokalemia and hydrochlororothiazide treatment on regression of Cornell product left ventricular hypertrophy in hypertensive patients : implications for the development of potassium-sparing diuretics (2009) (0)
PREVALENCE AND INCREASED SEVERITY OF PULMONARY HYPERTENSION AFTER TRANCATHETER AORTIC VALVE REPLACEMENT (2012) (0)
Changes in cardiac shape in the ischemic porcine heart does not contribute to the improvement in myocardial function following adenovirus-mediated gene transfer of cDNA for vascular endothelial growth factor (1998) (0)
Impact of Left Atrial Function on Cardiovascular Phenotype and Outcome in Arterial Hypertension: the Strong Heart Study (2005) (0)
Caridac and hemodynamic features of hypertension associated with diabetes: the strong heart study (1998) (0)
Arterial compliance in normotensive and hypertensive employed adults clinical and cardiac correlates (1989) (0)
Ambulatory Blood Pressure Monitoring (1984) (0)
The interface identified as the right side of the interventricular septum. (1994) (0)
Chronic aortic regurgitation in rabbits causes progressive left ventricular dilatation and eccentric hypertrophy (1986) (0)
INCIDENCE AND STRUCTURAL PREDICTORS OF AORTIC DISSECTION AMONG PATIENTS WITH GENETICALLY MEDIATED AORTIC ANEURYSMS: MULTICENTER FOLLOW-UP RESULTS FROM THE GENTAC (NATIONAL REGISTRY OF GENETICALLY TRIGGERED THORACIC AORTIC ANEURYSMS AND CARDIOVASCULAR CONDITIONS) REGISTRY (2014) (0)
[Mitral prolapse]. (1977) (0)
5.19 Correlation Among Renal and Cardiac Function and Left Ventricular Geometries: The Strong Heart Study (2008) (0)
9.17 Influence of Non-Haemodynamic Factors on Left Ventricular Mass in Adolescents with High Prevalence of Obesity: the Strong Heart Study (2008) (0)
Relative Impact of Surgical Mitral Repair and MitraClip on Annular Remodeling-A Potential Mechanism for Therapeutic Response to Mitral Repair for Degenerative Mitral Regurgitation. (2021) (0)
LOW IN-TREATMENT HDL CHOLESTEROL LEVELS STRONGLY PREDICT THE DEVELOPMENT OF NEW STROKE: THE LIFE STUDY (2013) (0)
Mitral Valve Prolapse: Symptom Complex or Valvular Heart Disease? (1993) (0)
Abstract 2592: Left Ventricular Mass and Incident Arterial Hypertension in Subjects with Initial Optimal Blood Pressure: The Strong Heart Study. (2006) (0)
Established binary cutoffs for cine-CMR basal slice selection - an unrecognized source of CMR discordance with echocardiography and necropsy derived LV mass (2013) (0)
The association between isolated systolic hypertension and aortic regurgitation is not independent of age: the strong heart study (2004) (0)
Is Cardiac Hypertrophy Compensatory or Harmful (2020) (0)
Electrocardiographic Di.agnosis of Left Ventricular 'Hypertr the Time-Voltage Integral of the QRS Complex LEFT `VENTRICULAR HYPERTROPHly (2016) (0)
Age-related changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The preserve study. (1999) (0)
1030-135 Impact of Wide Pulse Pressure With and Without High Systolic Blood Pressure on Clinical Outcomes in Chronic Severe Aortic Regurgitation (2004) (0)
Abstract 11046: Chronic Obstructive Pulmonary Disease and Sudden Cardiac Death in Hypertensive Patients: The LIFE Study (2015) (0)
P-416: Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy: the life study (2003) (0)
Heart rate is associated with markers of fatty acid desaturation: the GOCADAN study. (2012) (0)
1085-166 Does hormone replacement therapy in women influence their benefit of losartan-treatment in the LIFE study? (2004) (0)
1149-159 Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: The LIFE study (2004) (0)
Relation of the metabolic syndrome to cardiac markers of preclinical disease: The strong heart study (2003) (0)
Radionuclide angiographic assessment of repair VS replacement for mitral regurgitation (1995) (0)
Abstract 14265: Physical Activity Lowers Cardiovascular Mortality by Mediating Systemic Inflammation: The Strong Heart Study (2020) (0)
B9 - Comparisent of morpho-functional state of the heart of patients with essential hypertension and hyperaldosteronism (1995) (0)
Left ventricular systolic dysfunction predicts incremental utility of delayed enhancement CMR vs. echocardiography for diagnosis of LV thrombus (2009) (0)
Does Isolated Diastolic Dysfunction Exist in Hypertensive Patients With ECG Determined Left Ventricular Hypertrophy: The LIFE Study (1998) (0)
Differential impacts of hypertension and type 2 diabetes mellitus on arterial disease and cardiovascular outcomes: The strong heart study (2011) (0)
7.2 Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients during Anti-Hypertensive Treatment: the Life Study (2008) (0)
Hypertension and the Heart (1997) (0)
P-528: Pulse pressure and cardiovascular risk factors in patients with hypertension and ECG LVH: The life study (2001) (0)
Abstract 4198: Combination of Left Atrial Size and Function Improves Prediction of Incident Heart Failure: The Strong Heart Study (2008) (0)
Risks of electrocardiographic left ventricular hypertrophy in hypertensive individuals and benefits of treatment-induced regression (2009) (0)
Abstract 843: Exaggerated Left Ventricular Adaptive Response to Obesity in Women (2009) (0)
Abstract 15440: Prevalence, Mechanism, and Prognostic Significance of Myeloproliferative Neoplasm-Associated Right Ventricular Dysfunction (2017) (0)
RIGHT VENTRICULAR (RV) LINEAR DIMENSIONS ON ECHOCARDIOGRAPHY (ECHO) ARE RELIABLE INDICES OF CARDIAC MAGNETIC RESONANCE (CMR) QUANTIFIED CHAMBER REMODELING: A MULTIMODALITY VALIDATION STUDY (2016) (0)
Abstract 3172: Changes in Socioeconomic and Ethnic Disparities in the Use of Invasive Cardiac Procedures in Acute Myocardial Infarction Patients from 1995 to 2006 (2008) (0)
[Relationship between left ventricular mass and prognosis of arterial hypertension]. (1990) (0)
Abstract 3933: Genetic Linkage of Aortic Valve Sclerosis and Mitral Annular Calcification: The HyperGEN Study (2006) (0)
New Insights into Diastolic Dysfunction as the Cause of Acute Left-Sided Heart Failure Associated With Systemic Hypertension and/or Coronary Artery Disease (2002) (0)
Carotid anatomy and stiffness is not affected by hypercholesterolemia in uncomplicated essential hypertension (1996) (0)
Abstract 3001: Regression of the Electrocardiographic Strain Pattern Between Baseline and One Year of Antihypertensive Treatment is Strongly Associated With Regression of Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study (2006) (0)
Author’s response to reviews Title: Transcatheter MitraClip Repair Alters Mitral Annular Geometry – Device Induced Annular Remodeling on Three-Dimensional Echocardiography Predicts Therapeutic Response Authors: (2019) (0)
Link between systolic and diastolic dysfunction in hypertensive subjects with inappropriate left ventricular hypertrophy: the hyperGEN study (2002) (0)
METABOLIC PHENOTYPES AND CARDIOVASCULAR ABNORMALITIES IN PREDIABETES (2010) (0)
TCT-745 In-Hospital Clinical Outcomes Post Transcatheter Aortic Valve Replacement (TAVR) in Patients with History of Non-Cardiac Transplantation: Insights from the National Inpatient Sample (NIS) Database. (2016) (0)
Abstract 3267: Gender Difference in the Association of Aortic Valve Sclerosis and Cardiovascular Events in Hypertensive Adults with Left Ventricular Hypertrophy: The LIFE Study (2007) (0)
Recent Advances in Surgical Therapy for Patients With Valvular Heart Disease (2016) (0)
With Diabetes Cardiovascular Events During Differing Hypertension Therapies in Patients (2011) (0)
REDUCED ECG-LVH DURING ANTIHYPERTENSIVE THERAPY IS ASSOCIATED WITH LESS HOSPITALIZATION FOR HEART FAILURE IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION. THE LIFE STUDY: 1A.01 (2010) (0)
2.19 Are Coronary Revascularisation and Myocardial Infarction a Logical Combined Endpoint in Hypertension Trials? The Life Study (2007) (0)
1030-139 Prevalence and correlates of mitral regurgitation in hypertensive patients: The hypergen study (2004) (0)
ECHOCARDIOGRAPHIC ABNORMALITIES ARE COMMON AMONG PATIENTS WITH COVID-19 INFECTION AND INDEPENDENTLY CONFER INCREASED RISK OF IN-HOSPITAL MORTALITY (2021) (0)
The authors reply [16] (2006) (0)
Impact of vasodilator use on adverse events in chronic severe aortic regurgitation (2002) (0)
Abstract 11940: Aortic Complications Associated With Pregnancy in Marfan Syndrome: The NHLBI GenTAC Registry (2015) (0)
Abstract 3818: Combined Echocardiographic Left Ventricular Hypertrophy and Quantitative Electrocardiographic Strain Pattern Predict New-Onset Heart Failure: The Strong Heart Study (2006) (0)
Abstract 19085: Prevalence and Correlates of Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy (The LIFE Study) - Application of New Multivariate Predictive Models. (2010) (0)
Abnormal left ventricular structure and function are associated with new onset diabetes mellitus: the strong heart study (2002) (0)
[OP.7B.06] RELATIONSHIP OF INCIDENT ATRIAL FIBRILLATION TO THE ELECTROCARDIOGRAPHIC STRAIN PATTERN IN HYPERTENSIVE PATIENTS WITH ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY (2017) (0)
QRS duration predicts sudden cardiac death in hypertensive patients: The losartan intervention for endpoint reduction in hypertension (LIFE) study (2007) (0)
Abstract P038: Cadmium Exposure is Prospectively Associated to Cardiovascular Risk in the Strong Heart Study (2012) (0)
Abstract P038: Liver Enzyme Levels Are Associated With Metabolic Syndrome and Predict All-Cause and Cardiovascular Mortality in a High-Risk Population: The Strong Heart Family Study (2019) (0)
Abstract 3269: Association of Aortic Regurgitation with Cardiovascular Morbidity and Mortality in Hypertensive Patients with Left Ventricle Hypertrophy: The LIFE study (2007) (0)
Individualsaturatedfattyacidsareassociated withdifferentcomponentsofinsulinresistance andglucosemetabolism:theGOCADANstudy (2010) (0)
Antihypertensive Therapy (1966) (0)
Abstract 11259: Lower Achieved Systolic Pressure is Associated With Increased Short-Term Mortality After Stroke in Hypertensive Patients With Electrocardiographic Left Ventricular Hypertrophy (2014) (0)
The effect of baseline physical activity on cardiovascular outcomes in patients treated for hypertension with LVH. (2004) (0)
BLOOD PRESSURE LOWERING FOR THE SECONDARY PREVENTION OF STROKE : RATIONALEAND DESIGN FOR PROGRESS. DISCUSSION (1996) (0)
Left ventricular longitudinal shortening in hypertension (1996) (0)
Cardiac Features of Obesity in a Population of Adolescents (2005) (0)
Abstract 3224: Metabolic and Cardiovascular Characteristics of Diabetics in Adolescents and Young Adults: the Strong Heart Study (2008) (0)
IMPACT OF PRE-IMPLANTATION BALLOON VALVULOPLASTY ON PARAVALVULAR AORTIC REGURGITATION IN PATIENTS UNDERGOING BALLOON EXPANDABLE TRANSCATHETER AORTIC VALVE REPLACEMENT (2014) (0)
Is It Necessary to Demonstrate Changes in Left Ventricular Hypertrophy in the Evaluation of Antihypertensive Drugs (1990) (0)
Abstract 16704: Leukocyte Telomere Length and Risk of Stroke: The Strong Heart Family Study (2020) (0)
180 Determinants of central pressure waveforms in normotensive and hypertensive subjects (1993) (0)
16.11 Repeat testing of exercise ejection fraction at five years enhances prediction of adverse outcome in asymptomatic patients with chronic severe aortic regurgitation and normal ejection fraction at rest (2001) (0)
Three-Dimensional Echocardiography: in Vitro Validation of Left and Right Heart Cavity Volumes (1996) (0)
Abstract 19816: Effect of Diuretics on All-Cause Mortality and Cardiovascular Event Rates in Patients With Asymptomatic Aortic Stenosis (2016) (0)
STATIN USE AND RISK OF NEW DIABETES MELLITUS IN HYPERTENSivE PATIENTS: THE LIFE STUDY (2013) (0)
Abstract 16319: Distribution and Severity of Myocardial Ischemia Modify Mitral Regurgitation (MR) Response to Percutaneous Coronary Intervention (PCI) (2014) (0)
PERSISTENCE OR DEVELOPMENT OF NEW ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY BY BOTH CORNELL PRODUCT AND SOKOLOW-LYON VOLTAGE IS ASSOCIATED WITH MARKEDLY INCREASED RISK DURING ANTIHYPERTENSIVE THERAPY (2016) (0)
781-1 The Weak Relation Between Blood Pressure and Left Ventricular Mass is Partially Explained by Additional Effects of Hemodynamic Volume Load and Myocardial Contractility: The Strong Heart Study (1995) (0)
Effect of Selection Bias (2017) (0)
Association of hypokalemia with Cornell product left ventricular hypertrophy independant of treatment and blood pressure in hypertensive patients : implications for the development of new diurectic anthihypertensives (2009) (0)
Abstract 2376: Elevated Protein Z as a Risk Factor for Unexplained Cerebral Infarction: The THrombophilia In Cryptogenic stroKe (THICK) Study (2007) (0)
Abstract 11287: The Relationship of All-Cause Mortality to Average On-Treatment Systolic Blood Pressure is Significantly Related to Baseline Systolic Blood Pressure: Implications for Interpretation of the SPRINT Study (2016) (0)
Abstract 4434: Association of Elevated Serum Glucose Levels with Hypokalemia Independent of Treatment in Hypertensive Patients: Implications for the Development of New Diabetes (2008) (0)
Hypertensive Heart Failure (2012) (0)
Randomized Trial Cholesterol on Atherosclerosis in Diabetes : The SANDS Effect of Lower Targets for Blood Pressure and LDL (2008) (0)
RIGHT VENTRICULAR STROKE WORK INDEX AS PROGNOSTIC INDICATOR FOR POST-PROCEDURAL MORBIDITY AND 1-YEAR MORTALITY IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT (2014) (0)
Abstract P118: Gender Differences in Physical Activity Levels on Cardiovascular Events in Diabetes: The Strong Heart Study (2016) (0)
Abstract P136: Non-alcoholic Fatty Liver Disease Fibrosis Score Predicts The Development Of Carotid Atherosclerosis: The Strong Heart Family Study (2020) (0)
Abstract 20063: Association of Physical Activity With Cardiovascular Mortality With and Without Smoking: The Strong Heart Study (2017) (0)
Mitral annular calcification, aortic sclerosis, and incident stroke in American Indians free of clinical cardiovascular disease (2003) (0)
Low-Moderate Arsenic Exposure and QT Interval: the Strong Heart Study (2016) (0)
1163-118 Alcohol consumption and cardiac structure and function in American Indians: The strong heart study (2004) (0)
LOW IN-TREATMENT HDL CHOLESTEROL LEVELS STRONGLY PREDICT SUDDEN CARDIAC DEATH IN HYPERTENSIVE PATIENTS: THE LIFE STUDY (2012) (0)
EFFECT OF ANTIHYPERTENSIVE THERAPY ON DEVELOPMENT OF INCIDENT CONDUCTION SYSTEM DISEASE IN HYPERTENSIVE PATIENTS: THE LIFE STUDY (2017) (0)
Impact of systolic hypertension and impedance lowering drugs on clinical outcomes in chronic severe aortic regurgitation (2003) (0)
Abstract 11615: Influence of Age and Gender on Marfan Phenotype: The NHLBI GenTAC Registry (2016) (0)
Left atrial strain quantification by intraoperative transesophageal echocardiography: Validation with transthoracic echocardiography (2021) (0)
Iconographies supplémentaires de l'article : Lung Function and Heart Disease in American Indian Adults With High Frequency of Metabolic Abnormalities (from the Strong Heart Study) (2014) (0)
Losartan reduces hospitalization for heart failure in patients with diabetes and no prior history of heart failure (2003) (0)
P Pediatric and Adolescent Heart Disease mpact of Obesity on Cardiac Geometry nd Function in a Population of Adolescents he Strong Heart Study (2006) (0)
P-212: The effect of losartan versus atenolol on carotid atherosclerosis in the common carotid arteries in hypertension. Icarus, a life substudy (2004) (0)
P-529: Association between oxygen delivery and left ventricular mass diastolic dysfunction in hypertensives with electrocardiographic left ventricular hypertrophy: The life study (2001) (0)
Abstract P296: Joint Impact of 61 Genetic Variants in Seven Nicotinic Acetylcholine Receptor Genes on Subclinical Atherosclerosis in American Indians: A Pathway-based Analysis (2012) (0)
Abstract 12521: Cardiovascular Phenotype in Sarcopenic Obesity. (2010) (0)
Detection of abnormal LV function in mitral regurgitation by echographic mitral-septal separation. (1982) (0)
PREVALENCE AND CORRELATES OF AORTIC DILATATION IN ADOLESCENTS AND YOUNG ADULTS: THE STRONG HEART STUDY. (2010) (0)
50 Effect of salt intake on left ventricular performance in Goldblatt hypertension (1993) (0)
Abstract 6245: Evidence for Increased Left Ventricular Chamber Stiffness in Type 2 Diabetes: The Strong Heart Study (2008) (0)
Principal Component Analysis of the T Wave and Prediction of Cardiovascular Mortality (2002) (0)
2.18 Interaction of Metabolic Syndrome and Left Ventricular Hypertrophy in the Prediction of Cardiovascular Risk: the Strong Heart Study (2007) (0)
Letter to the editorThe reply (1988) (0)
763-1 Assessment of Left Ventricular Function by Circumferential Stress-Midwall Shortening Relations in Dilated Cardiomyopathy (1995) (0)
A year since JNC 7: What's new about hypertension (2004) (0)
24-hour ambulatory blood pressure in patients with ECG determined left ventricular hypertrophy: the life study. (1999) (0)
Abstract 12346: Aortic Valve Imaging in Aortic Stenosis - A Network and Pairwise Meta-analysis (2019) (0)
Cardiac Safety of ECT (1993) (0)
Abstract 20657: The Incidence and Risk of Hypokalemia in Patients With High Risk Hypertension: The ACCOMPLISH Study (2010) (0)
Abstract 3629: Socioeconomic and Ethnic Disparities in the Use of Biventricular Pacemakers in Heart Failure Patients with Left Ventricular Systolic Dysfunction (2007) (0)
RISK OF CARDIOVASCULAR AND ALL-CAUSE MORTALITY AS A FUNCTION OF RESTING HEART RATE IN ASYMPTOMATIC AORTIC STENOSIS: THE SEAS STUDY (2014) (0)
Abstract 2412: Multidetector Computed Tomography For the Identification of Left Atrial Thrombus in Patients Undergoing Pulmonary Vein Isolation (2006) (0)
Abstract 15170: Telomere Length and Incident Carotid Atherosclerosis (2013) (0)
REPORTS : CARDIOVASCULAR DISEASE AND RISK FACTORS ACUTE MYOCARDIAL INFARCTION QUALITY OF CARE : THE STRONG HEART STUDY (2011) (0)
Abstract 11223: Hydrochlorothiazide Use is Independently Associated With a Decreased Risk of New Atrial Fibrillation in Hypertensive Patients With Electrocardiographic Left Ventricular Hypertrophy (2014) (0)
Are left ventricular mass, geometry, and function related to vascularchanges and/or insulin resistance in longstanding hypertension? A LIFE substudy (2002) (0)
Abstract 18185: Regression of Severe Left Ventricular Hypertrophy After Transcatheter Valve Replacement for Aortic Stenosis: Impact on Clinical Outcomes in PARTNER Cohort A (2013) (0)
Abstract 1342: Initial Left Ventricular Mass Predicts Probability of Optimal Blood Pressure Control in Arterial Hypertension (2009) (0)
Abstract 11917: Angiotensin-Converting Enzyme Inhibitors are not Associated With Increased Sudden Cardiac Death, Cardiovascular Mortality or All-cause Mortality In Patients With Mild to Moderate Aortic Stenosis - The SEAS Study (2012) (0)
TCT-709 Trans-apical Transcatheter Aortic Valve Replacement in Patients with History of Coronary Artery Bypass Grafting: An Analysis from the National Inpatient Sample Database. (2016) (0)
Left ventricular mass as a surrogate endpoint in the treatment of hypertension (1997) (0)
Abstract 17235: Physical Activity Reduces Cardiovascular Mortality in Albuminuria: The Strong Heart Study (2016) (0)
Herz Ventricular Hypertrophy and Hypertension Prognostic Elements and Implications for Management (0)
Complications of Hypertension (2005) (0)
EFFECT OF BETA-BLOCKADE ON CARDIOVASCULAR EVENT RATES IN PATIENTS WITH ASYMPTOMATIC AORTIC STENOSIS (2015) (0)
RISK FACTOR BURDEN IN DIABETIC ADULTS WITH KNOWN CARDIOVASCULAR DISEASE IS ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY AND DYSFUNCTION: THE STRONG HEART STUDY (2010) (0)
RELATION OF CARDIOVASCULAR STRESS REACTIVITY TO LEFT VENTRICULAR MASS AND RELATIVE WALL THICKNESS IN HYPERTENSIVES: EFFECTS OF RACE AND GENDER (1999) (0)
THE EFFECT OF BASELINE PHYSICAL ACTIVITY ON CARDIOVASCULAR OUTCOMES IN PATIENTS TREATED FOR HYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY: P3.323 (2004) (0)
ASSOCIATION OF INSULIN RESISTANCE WITH PRECLINICAL CARDIOVASCULAR DISEASE IN ADOLESCENTS AND YOUNG ADULTS: THE STRONG HEART STUDY. (2010) (0)
Determinants of ECG LVH. (1980) (0)
REPORTS : CARDIOVASCULAR DISEASE AND RISK FACTORS SOCIOECONOMIC AND ETHNIC DISPARITIES IN THE USE OF BIVENTRICULAR PACEMAKERS IN HEART FAILURE PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (2013) (0)
Relation of impaired glucose tolerance to cardiac structure and function: the strong heart study (1998) (0)
Stroke outcomes in life (2003) (0)
Abstract 16565: Impact of Gender on Myocardial Infarction Burden and Post-Myocardial Infarction Remodeling (2017) (0)
Abstract 15176: Incremental Utility of Echocardiographic Strain for Assessment of Myocardial Infarct Size and Thrombus as Assessed via Cardiac Magnetic Resonance Tissue Characterization (2017) (0)
Abstract 2544: The Relationship Between Left Ventricular Mass Measured by Magnetic Resonance Imaging and Echo-Doppler Parameters of Diastolic Function in Hypertensive Patients with Echocardiographic Left Ventricular Hypertrophy: The ALIVE Study (2006) (0)
Abstract 16011: Prospective Associations of Left Atrial Size and Function With Cardiovascular Disease in American Indians: The Strong Heart Study (2016) (0)
Abstract 2373: Cardiac Structural and Functional Correlates of C-reactive Protein in a Population with High Prevalence of Diabetes and Hypertension: The Strong Heart Study (2006) (0)
Abstract P211: Prediction of Stroke in a Population with High Prevalence of Diabetes: The Strong Heart Study (2013) (0)
Abstract MP31: Blood DNA Methylation Signatures of Incident Coronary Heart Disease: An Epigenome-wide Analysis in the Strong Heart Study (2020) (0)
Abstract P117: Physical Activity Decreases Cardiovascular Events via an Inflammatory Pathway: The Strong Heart Study (2016) (0)
Left ventricular structure and function in patients with isolated systolic or diastolic hypertension (1998) (0)
Normal values for ascending aortic diameters with 2D echocardiography (2013) (0)
Abstract 19856: No Impact of Weight Gain on Blood Pressure and Left Ventricular Mass Variation in Hypertensive Patients with Left Ventricular Hypertrophy: the LIFE Study. (2010) (0)
Abstract 17067: Circulating Lipoprotein (a) Level, Apolipoprotein (a) Isoform Size, and Risk of Unexplained Ischemic Stroke in Younger Adults (The THrombophilia in Cryptogenic stroKe [THICK] Study) (2014) (0)
Prediction of coronary artery disease in patients with diabetes and albuminuria (2007) (0)
Early changes in left ventricular function and geometry in patients with mild mitral or aortic regurgitation. the life study (1999) (0)
Prediction of indications for valve replacement in patients with aortic regurgitation (1995) (0)
MITRAL REGURGITATION Mitral regurgitation : relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients (2005) (0)
16.14 Assessment of temporal changes in right-and left-ventricular function and size in patients with asymptomatic chronic severe non-ischaemic mitral regurgitation (2001) (0)
Abstract WP266: Association between Left Ventricular Ejection Fraction, Wall Motion Abnormalities and Embolic Strokes of Undetermined Source (2019) (0)
CRT-800.19 Outcomes of Intra Aortic Balloon Pump use in Surgical and Transcatheter Aortic Valve Replacement (2017) (0)
OR-10: Prevalence and correlates of aortic valve sclerosis in hypertensive adults: The hypergen study (2003) (0)
Abstract 9424: Low In-Treatment HDL Cholesterol Levels Strongly Predict the Development of New Diabetes Mellitus: The LIFE Study (2010) (0)
Abstract 12670: New-Onset AF Increases All-cause Mortality and Cardiovascular Death in a First-time Myocardial Infarction Population - A Nationwide Propensity Score Matched Study (2012) (0)
32. Effect of sodium intake on left ventricular anatomy in rats with one-kidney, one clip and two-kidney, one clip Goldblatt hypertension (1991) (0)
B36 - Obesity does not worsen systolic function in arterial hypertension (1995) (0)
4th International Symposium on the Marfan Syndrome, 1st International Workshop for People with Marfan Syndrome, Dovos, Switzerland, 11–14 August 1996 (2005) (0)
GENOME-WIDE LINKAGE MAPPING FOR LEFT VENTRICULAR DIASTOLIC FUNCTION PHENOTYPES IN AMERICAN INDIANS: THE STRONG HEART FAMILY STUDY (2011) (0)
1030-138 Valvular regurgitation predicts cardiovascular mortality and morbidity among American Indians: The strong heart study (2004) (0)
Abstract 10381: Improved Left Ventricular Mass Quantification with Partial Voxel Interpolation - in vivo and Necropsy Validation of a Novel Algorithm for Automated Analysis of Cardiac Magnetic Resonance (CMR) (2011) (0)
EFFECT OF RANDOMIZED LIPID LOWERING WITH SIMVASTATIN AND EZETIMIBE ON CATARACT DEVELOPMENT: THE SEAS STUDY (2014) (0)
Echocardiography in the Evaluation of Coronary Artery Disease (1999) (0)
Repolarization complexity and abnormality for prediction of all-cause and cardiovascular mortality: The strong heart study (2003) (0)
The "Green Journal"--progress and continuity. (1980) (0)
Abstract 9199: Racial Differences in Incident Atrial Fibrillation Among Hypertensive Patients During Antihypertensive Therapy: The LIFE Study (2010) (0)
Abstract 5862: Development of Systolic Dysfunction Not Related to Myocardial Infarction in Treated Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Echo Substudy (2009) (0)
Letter: More on "Munchausen syndrome". (1974) (0)
Left ventricular midwall function in systemic hypertension. (1998) (0)
The LIFE sudy (2005) (0)
IMPACT OF IMAGING METHODOLOGY ON MEASUREMENTS OF AORTIC SIZE IN PATIENTS WITH THORACIC AORTIC ANEURYSMS - RESULTS FROM THE GENTAC IMAGING DATABASE (2010) (0)
Stroke Association Between Major Perioperative Hemorrhage and Stroke or Q-Wave Myocardial Infarction (2012) (0)
Abstract 5419: Hypokalemia Blunts Left Ventricular Mass Regression in Hypertensive Patients During Losartan- or Atenolol-Based Treatment: The LIFE Echo-substudy (2009) (0)
VALIDATION OF VANCOUVER AND CEDARS-SINAI CARDIAC COMPUTED TOMOGRAPHY ANNULAR SIZING GUIDELINES FOR BALLOON-EXPANDABLE TRANSCATHETER AORTIC VALVE REPLACEMENT (2014) (0)
CLINICAL CHARACTERISTICS OF AORTIC DISSECTION IN BICUSPID AORTIC VALVE DISEASE; PRELIMINARY DATA FROM THE GENTAC REGISTRY (2011) (0)
Abstract 277: The Relationship Between Aortic And PA Diameter Among Individuals With Genetic Conditions Of The Thoracic Aorta: A Report From The NIH Gentac Registry (2012) (0)
Prevalence of panic disorder in relatives. (1986) (0)
P-148: Is NT-pro brain natriuretic peptide related to left ventricular mass as well as wall stress? The life study (2003) (0)
Arterial Stiffness, Central Blood Pressure and Cardiac Remodelling: From Cardiac Hypertrophy to Heart Failure (2014) (0)
Relation of left ventricular contractile efficiency to demographic, metabolic and anatomic cardiovascular risk factors (1996) (0)
Impact of different partition values on prevalences of left ventricular hypertrophy and geometry: The life study (1999) (0)
2030 Established cmr methods for left ventricular quantification differ based on variable exclusion of papillary/trabecular volumes: increased diagnostic impact among patients with left ventricular hypertrophy (2008) (0)
Outcome prediction after aortic valve replacement for aortic regurgitation (1999) (0)
P-516: Impact of blood pressure on cardiac structure and cardiovascular outcome in the metabolic syndrome: The strong heart study (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Richard Blyton Devereux?

Richard Blyton Devereux is affiliated with the following schools:

Richard Blyton Devereux's Academic­Influence.com Rankings

Richard Blyton Devereux's Degrees

Why Is Richard Blyton Devereux Influential?

Richard Blyton Devereux's Published Works

Published Works

What Schools Are Affiliated With Richard Blyton Devereux?

Richard Blyton Devereux's AcademicInfluence.com Rankings